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The ability to create protein variants is a very valuable tool in biochemistry. 
Information about mechanistic roles of amino acid side chains, protein topology and 
binding can all be obtained. Methodologies to mutate proteins also allow for new 
catalytic activity to be achieved. While the routinely used methods to alter a protein 
sequence have proven to be useful, to some degree each of these methods requires 
some knowledge of protein structure to determine the site of mutation. Further, the 
routinely used methods also only allow for a specified site to be changed to a pre-
determined residue (directed by oligonucleotides) or for multiple random sites to be 
changed to a non-specified residue. This dissertation focuses on the development of a 
method that allows for a new defined amino acid to replace a native amino acid at a 
random location within in the protein. 
  
To introduce mutations at random locations within a protein coding sequence, 
three steps need to be accomplished. First, the coding sequence needs to be randomly 
digested on both strands; second, three nucleotides (a codon) at the digestion site need 
to be removed; and last, a new specified codon inserted. This process results in the 
replacement of a random codon with the new defined codon. To direct a mutation at a 
random location, the unique properties of a transposase/transposon are used to create 
both the double strand break and removal of three nucleotides. The insertion of the 
new defined codon is introduced using a linker sequence that when inserted in the 
correct reading frame a selectable phenotype is produced. This process has been 
termed Codon Scanning Mutagenesis (CSM). 
The advantages of this method over current mutagenesis methods are (1) 
knowledge of structural information is not required, (2) oligonucleotides are not 
required to introduce the mutation and (3) the mutagenesis method allows for every 
amino acid to be mutated regardless of the DNA sequence. Further, this method 
allows for any natural and unnatural amino acid to be inserted at the mutation site, as 
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Proteins can be compared to a string of beads, where each bead is called an 
amino acid. In nature there are 20 different amino acids that can carry a charge 
(positive, negative or neutral) or contribute to structural aspects of the protein. These 
characteristics that distinguish one from the other are determined by what is called a 
functional group or side chain. The order of the amino acids dictates the function of 
the protein and is determined by a three letter code in the deoxyribonucleic acid 
(DNA).  DNA is made up of four units, adenine (A), cytosine (C), guanine (G), and 
thymine (T). These four units are assembled into 64 three letter words called a codon. 
Proteins can be studied by altering a codon, resulting in the coding of a new amino 
acid.  
Described in this thesis is a method that has been termed Codon Scanning 
Mutagenesis (CSM). This method allows for each three letter code to be randomly 
changed, resulting in the replacement of an amino acid. The replacement is done in 
three simple steps, first a circular piece of DNA is cut in a random place, second a 
codon is removed, third a different codon is added and the circle is closed. The 
recoding of the sequence will result in a new amino acid in place of the old. The 
result of subjecting a protein to CSM is depicted on the following page, where the red 
bead is scanned throughout the protein sequence, resulting in every variation. 
Prior to the development of CSM, specific codons could be introduce at a 
specified location in the DNA sequence or mutations are incorporated a random 
location without the ability to specify which codon. CSM is a novel method in that a 








Chapter 1: Background and Significance 
1.1 Information that can be gained from protein mutagenesis 
The ability to change amino acid residues within a protein has had a profound 
impact in the biochemistry field. Mutating protein sequence allows for both mechanistic 
and structural information to be obtained, as well as the creation of proteins with 
improved or unique function. Protein mutagenesis allows for the identification of specific 
residues that are responsible for protein-protein interactions by mutating those residues 
that are believed to be responsible for binding. A classical example of such an experiment 
was performed by Wells and co-workers where the binding of the human growth 
hormone (hGH) receptor was investigated by introducing alanine mutations.1 Alanine is 
chosen because all side chain interactions are eliminated and typically this amino acid 
does not alter the overall conformation of the protein. The dissociation constant of each 
mutant protein was then compared with the wild-type and the residues that are crucial for 
binding were revealed. 
Differences in highly conserved sequences of protein homologs are often target 
sites to introduce mutations. For example, when the sequence of the highly conserved 
binding site of uracil phosphoribosyltransferase (UPRT) was compared with other 
phosphoribosyltransferases (PRTase) a proline residue was observed in the active site of 
UPRT where as other PRTases have an aspartic acid at the corresponding site.2 To 
determine if this proline was responsible for activity, an aspartic acid mutation was 
introduced in place of the proline. Various kinetic and binding assays were performed on 




was observed for the P131D variant, indicating that the proline is essential for substrate 
binding. 
Introducing amino acid mutations into a protein can also result in the creation of a 
protein with an improved function. Raines and co-workers demonstrated this by 
increasing the affinity of a protein to the cell wall by the introduction of a cationic 
patch.3, 4 A cationic patch results from site-specifically replacing native residues located 
on the surface of the protein with arginine residues. The creation of this cationic patch 
increases the affinity of the protein to the cell wall and promotes internalization of the 
protein. It has been reported that the guanidinium groups of arginine interact with the 
lipids or heparin sulfate proteoglycans (HSPG)5 and results in internalization.6, 7 The 
addition of guanidinium groups increases the number of hydrogen bonds promoting 
sufficient cellular uptake.8, 9 
As a proof of concept, Raines and coworkers proved that a protein can be 
internalized by the addition of a cationic patch. Protein internalization was demonstrated 
using green fluorescent protein (GFP) which has a net charge of -9 at neutral pH and has 
both acidic and basic residues on one face of the protein. Mutating five of the acidic 
residues on this face to arginine created a cationic patch on the surface of the protein. 
Incubation of the mutant protein with HeLa cells revealed that the cationic GFP was 
internalized.3 Using the idea of altering the surface of a protein to have a higher affinity 
for the cell wall, arginine mutations were introduced in to ribonuclease (RNase A). It was 
found that the variants of RNase A that have the cationic surface had an increase of 
cytotoxicity and inhibited cell proliferation by 3-fold4 as measured by the incorporation 




Structural information can also be determined by altering protein sequence. This 
is particularly useful for proteins in which it is difficult or impossible to obtain an X-ray 
crystal structure, such as transmembrane or multi-domain proteins. Topological 
information can be obtained by scanning cysteine accessibility mutagenesis (SCAM)11      
(Figure 1.1). Using sulfhydryl chemistry it is possible to locate amino acid positions that 
are both intracellular and extracellular. The positions of amino acids can be determined 
by labeling the whole protein with a membrane permeable sulfhydryl reagent that carries 
a biotin tag. Any positions that are not in the plane of the bilayer will be labeled. Only 
positions that are intracellular can be identified by incubating with a non-permeable 
reagent capable of blocking free thiols followed by a membrane permeable reagent that 
carries a biotin label. The only requirement is that the mutant contains one cysteine 
residue.11 Additionally solvent exposed residues can be mapped by introducing cysteines 
and reacting with cyanylation reagent, such as 2-nitro-5-thiocyanobenzoic acid (NTCB) 
or 1-cyano-4-dimethylaminopyridinium tetrafluoroborate (CDAP). The reagent will only 
react with thiol groups which are exposed to solvent which then allows for peptide 
cleavage catalyzed by ammonia. Any mutant that has an extracellular cysteine will be 





Figure 1.1: Determination of topology using SCAM. 
SCAM allows for the location of cysteine residues in a transmembrane protein to be determined. (A) 
Cysteines (pink) within membrane proteins (brown) can occupy three different environments. On the left 
outlines the pre-blocking protocol, where a membrane-impermeable sulfhydryl reagent (X) reacts with 
cysteine residues which are extracellular. Both the blocked and unblocked pool is treated with a membrane-
permeable regent (B) and introduces a biotin tag intracellular as well as to those which are extracellular in 
the unblocked pool. (B) Location of the residues can be determined by comparing the amount of biotin 
incorporated in both the blocked and non-blocked protocols.  
 
Introducing protein mutations can also be valuable in understanding protein 
folding. By changing a side chain that may be involved in the formation of the tertiary 
structure to one of the other naturally occurring amino acids would alter the overall 
stability of that secondary structural element. The mutant can then be analyzed by 
absorbance, fluorescence or circular dichroism spectroscopy.13 Altering the primary 
structure of a protein does not necessarily have to be detrimental to overall protein 
stability but rather can be beneficial by randomly introducing mutations to increase the 
rate at which the mature protein is formed. An example of a protein that has been evolved 




green fluorescent protein (sfGFP).14 Waldo and co-worker randomly introduced 
mutations into GFP by fragmenting the gene and reassembling the random fragment 
multiple times. After each round of randomization the brightest clones were chosen. The 
kinetics and stability of sfGFP was then determined, it was found that the variant folds at 
a rate of 5.0 x 10-1 s-1 making it the fastest folding GFP variant. It was also found that 
sfGFP is folded and forms a mature chromophore even when fused to non-soluble protein 
domains. The mutations that were introduced into sfGFP are all solvent exposed except 
for one. The stability of the sfGFP can be attributed to increasing electrostatics, 
increasing H-bonding, and increasing non-polar interactions.14 
Not only is protein mutagenesis a valuable tool to aid in the understanding of 
protein structure or function,  but directed evolution has been shown to enhance protein 
function. Directed evolution can be used to create catalysts for organic reactions. This has 
been demonstrated using cytochrome P450s (P450) as a catalyst for difficult organic 
reactions, such as hydroxylation of linear alkanes15 or enantioselective epoxidation.16 The 
substrate specificity of enzymes can also be altered to create new function. It has been 
shown that non-native amino acids can be genetically encoded by introducing mutations 
into both the enzyme and substrate, in this case, an aminoacyl transferase and tRNA.17 
The introduction of non-native functional groups is further described in section 1.3. 
While several examples of the usefulness of protein mutagenesis have been described 
here, nearly all reports of studying proteins involve introducing mutations.  
1.2 Traditional approaches to protein mutagenesis 
A general method that allows for a desired change in a gene sequence to be made 




gene19 and synthesize short segments of DNA (oligonucleotides) made it possible to 
introduce site specific mutations in the DNA sequence.  Smith’s invention of site-directed 
mutagenesis was further enhanced by the development of polymerase chain reaction 
(PCR) by Mullis.20 Both site-directed mutagenesis and PCR have had a profound impact 
on the field of biochemistry and has facilitated numerous studies to be conducted on 
proteins.  
The sequence of a protein is dictated by the nucleotides that comprise the codons 
of the gene. To create mutations in a protein sequence involves changing the DNA 
sequence. There are many ways in which a change in the DNA sequence can be 
performed. Site-directed approaches, section 1.2.1, allow specific changes in the DNA 
sequence to be made. Not only are site-directed approaches used in creating amino acid 
changes, but it can be a useful method in synthetic biology to generate silent mutations 
allowing for the removal of unwanted restriction endonuclease sites. Apart from site-
directed approaches there are several random approaches that incorporate mutations at a 
non-specified site. Random mutagenesis approaches, discussed in 1.2.2, allow for gene 
libraries to be generated and leads to evolution of new protein function. Nearly all of the 
current methods that are used to introduce mutations, either site-specifically or random, 
are in vitro and involve the use of PCR and a unique set of oligonucleotides. 
Additionally, either chemical mutagens21 or UV light22 can promote DNA mutations 
which lead to protein variants. 
1.2.1 Site-directed approaches to protein mutagenesis 
Introducing a site-specific codon mutation is fairly simple with the use of 




oligonucleotide that has been designed to contain a mutation. The methods described are 
based on Smith’s early development of site-directed mutagenesis, which involved 
synthesizing a mutagenic oligonucleotide, annealing of the oligonucleotide to single 
stranded plasmid DNA, extending the new mutant strand with DNA polymerase I 
followed by ligation to yield a heteroduplex molecule (Figure 1.2 A).18  
Kunkle and co-workers made great improvements on Smith’s early site-directed 
approach. The method termed Kunkle mutagensis,23 is in many ways similar to the 
original site-directed mutagenesis method. The Kunkle method involves first isolating 
plasmid DNA from an E. coli strain that lacks both dUTPase and uracil deglycosidase. 
Plasmid DNA that is isolated from this strain of E. coli will be single stranded and have 
uracil in place of thymine. The mutation is then inserted by a single mutagenic oligo, 
polymerase to synthesize the second strand, followed by ligation. The duplex DNA, 
where one strand lacks thymine and the other contains the wanted mutation is then 
transformed into E. coli, where through replication would remove the uracil containing 
strand, leaving only duplex DNA that has the specified mutation, as depicted in Figure 
1.2 B. 
While, Smith’s and Kunkle’s site-directed mutagenesis methods are useful, a 
disadvantage is the requirement that the plasmid containing the gene of interest must be 
single stranded. This requires using phage plasmid or isolation of the DNA from a 
particular strain and therefore can be a time consuming process. With PCR, generating 
mutations is faster and more reliable, than either of the two previously described 
methods, since the DNA strand containing the mutation is amplified exponentially. One 




inverse PCR (EIPCR).24 In this method, the entire plasmid containing the gene of interest 
is amplified. To incorporate the mutation a set of oligonucleotides is used, one of which 
has the mutation. In addition to the mutation in the oligonucleotide, unique restriction 
sites, typically type IIS endonuclease which cut outside of the recognition sequence, are 
designed such that after a successful amplification of the plasmid, the product can be 
digested. Removal of the restriction site, followed by successful ligation leaves the 
desired mutation, as shown in Figure 1.2 C.  
One of the most widely used methods was developed by Stratagene, termed the 
“Quikchange” method. The one requirement for this method is that the plasmid DNA is 
isolated from an organism that methylates DNA. While this requirement seems similar to 
that of the Kunkle method, it differs in that nearly all routinely used E. coli strains carry 
the genes for DNA methylases. A set of unique oligonucleotides are required to change a 
specific codon in the protein coding sequence. These mutagenic oligonucleotides are 
designed so that either one or both contain the mutation of interest; additionally the 
oligonucleotides used are either partially or exact complements of each other. After 
successful PCR amplification using a high fidelity polymerase the methylated parent 
DNA can be removed by digesting with DpnI, an endonuclease that recognizes only 
methylated DNA (DNA from a PCR reaction is not methylated), as shown in Figure 1.2 
D. Not only can the described site-directed methods be utilized to change a codon, 






Figure 1.2: Comparison of site-directed mutagenesis methods. 
All 4 methods depict creating an Asn to Ala mutation by mutating AAC to GCG. (A) In Smith’s approach 
of site-directed mutagenesis, the parental DNA must be isolated form phage so that it is single stranded. 
This method resulted in obtaining both the parental DNA as well as the mutant. (B) In the Kunkle approach 
plasmid DNA is isolated from Ung- E. coli, the mutation of interest is incorporated site specifically and the 
parental DNA is destroyed when transformed into an Ung+ strain. (C) EIPCR, does not involve isolating 
the parental DNA from a specific strain. Both strands are amplified in a traditional PCR reaction, to contain 
the mutation of choice and a unique restriction site (R.S.) The mutation is then introduced by digestionand 
re-ligation. In the last example (D) Quikchange mutagenesis, the additional step processing step in EIPCR 




1.2.2 Random approaches to protein diversification 
Several approaches to randomly diversify proteins have been developed. The 
directed evolution of a protein requires that several non-specific mutations are 
incorporated into the DNA sequence followed by a high throughput screen or genetic 
selection that facilitates the isolation of a desired phenotype. One widely used approach is 
error-prone PCR. This method is based on traditional PCR that amplifies DNA, however 
by changing the concentration of either Mn2+ or Mg2+ in the reaction buffer, the fidelity 
of Taq polymerase can be altered. This results in mismatched bases during the 
amplification process, as depicted in Figure 1.3 A.25 
A method that does not change the DNA sequence, but instead recombines the 
mutations from different strands of sequence in segments, is DNA shuffling.26 This 
method is most commonly combined with error prone PCR and is comprised of 
fragmentation with DNase I and the desired length of the randomized fragments is 
isolated, smaller fragments favor more recombination. The isolated fragments are then 
reassembled by PCR without terminal primers. Since fragments will overlap, the 
fragments themselves act as primers, annealing to other fragments in the mixture. The 
recombined gene is then amplified with terminal primers and cloned into an expression 
vector and screened for desired phenotype, as shown in Figure 1.3 B. After those mutants 
which have the desired function are combined, multiple rounds of shuffling can be 
preformed. This method also allows for similar genes from different organisms to be 
recombined, however a constraint is that there is a limitation on the fragmented genes 




In an effort to create a method that is not dependent on sequence homology, non-
homologus random recombination has been proposed.27 Similar to DNA shuffling, the 
starting DNA pieces are digested with DNAse to create random fragments of a desired 
length. Unlike DNA shuffling, the fragments are then joined with ligase and capped on 
the ends to control the gene length with hairpins. DNA hairpins are single stranded DNA 
that has a complementary sequence on either end. Within the hairpin, there is an internal 
restriction site and oligonucleotides can anneal to the hairpins to amplify the recombined 
gene, see Figure 1.3 B. 
There are many other ways to randomly create protein variants. One method is 
circular permutation. This technique utilizes the randomness of DNAse to introduce a 
single double strand break within a circular gene resulting in fusion of the N- and C- 
termini. The gene encoding the protein of interest is amplified with oligonucleotides that 
contain DNA coding for a protein region of flexibility, typically this linker segment 
would have a high percentage of glycine residues. Ligation of the PCR product to itself 
results in a double stranded circular gene.  The circular gene is then treated with DNAse 
in the presence of Mn2+. The randomly linear DNA segment is then inserted into an 
expression plasmid and assayed for desired function.28 Specific insertions can also be 
incorporated into a protein, using commercially available kits. This method is controlled 
by using mobile genetic elements called transposons, described in 3.2.1, and have been 
optimized to target DNA once. The random insertion of a linker sequence is useful in 
determining gene function or identifying regions of flexibility in a protein. One kit is the 
Mutation Generation System (MGS) kit (Finnzymes). This kit utilizes a transposon to 




with an endonuclease, followed by ligation leaving a “scar” in the protein coding 
sequence. This scar is a 15 bp insertion or a five amino acid linker that has been 
randomly inserted, as shown in Figure 1.3 C. By scanning a five amino acid linker 
throughout the gene encoding β-galactosidase, Savilahti found that every mutant 
contained a 15 bp insertion and the site of insertion was randomly disturbed. Using the 






Figure 1.3: Comparison of irrational approaches to protein diversification. 
Depiction of irrational protein diversification approaches. (A) Error prone PCR, lowering the fidelity of 
Taq polymerase results in random nucleotide mis-matches, represented by *. (B) In recombination genes of 
interest; red, blue and green, are randomly fragmented. In DNA shuffling the fragments are combined by 
PCR without the use of external oligonucleotides. The desired length is then amplified with external 
oligonucleotides. This method requires that there is homology between different fragments. On the right 
shows non-homologus recombination, where T4 ligase is used to form the desired length gene. (C) 




An all in vivo method that is used to diversify a gene sequence is to use a strain of 
E. coli that has the DNA repair pathways deleted. The three DNA repair pathways that 
have been deleted are mutS, which repairs mismatches; mutD, responsible for 3’- to 5’ 
exonuclease of DNA polymerase III and mutT, making the strain unable to hydrolyze 8-
oxo-dGTP. Transforming plasmid DNA into a commercially available strain from 
Stratagene, XL1-red, which lacks these DNA repair pathways, will promote mis-matches 
in DNA during the replication process. Additionally, a temperature sensitive plasmid 
carrying the mutD5 gene30, can be used in place of using the mutator strain XL1-red. 
Random mutations are introduced into the target DNA by co-transformation of the 
mutD5 plasmid and target plasmid. By adjusting the growing temperature conditions the 
E. coli can be cured of the mutD5 carrying plasmid. This method creates a temporary 
mutator strain, resolving one of the disadvantages to using the XL1-red strain. While the 
plasmid carrying the target gene is replicated mutations are also incorporated into the 
chromosome making the strain non-viable after long growth times.  
1.3 In vivo incorporation of unnatural amino acids 
With recent developments introducing a mutation into a protein is not limited to 
only the 20 natural amino acids. Schultz and coworkers have been able to expand the 
genetic code to incorporate non-native amino acids in vivo. The introduction of these 
unique amino acids into a protein sequence allows for new chemical experiments to be 
performed that would otherwise be difficult or impossible. For instance none of the 20 
natural amino acids contain a keto group. With the expanded genetic code technology, it 
is possible to incorporate p-acetylphenylalanine, whose carbonyl group under 




fluorescent dyes or biotin.31 Two other chemical handles that can be incorporated include 
azides32 or alkynes.33 These functional groups can be further modified by copper 
catalyzed cycloaddition or Staudinger ligation. This methodology also enables the control 
of protein function with light. The binding affinity of a protein can be controlled by the 
addition of p-phenylalanine-4’-azobenzene,34 which has a photo-isomerizable double 
bond changing both structure and dipole. Protein activity can also be regulated by 
incorporating photo-removable protecting groups, which can block a biological reaction 
from occurring until the group has been removed.35 Structural information can also be 
probed by incorporating a photo-cross-linking amino acid, p-benzoylphenylalanine,36 
which allows the isolation and characterization of protein-protein, protein-ligand37 or 
protein-DNA interactions.38 
 
Figure 1.4: Examples of unnatural amino acids used to incorporate unique function 
in vivo.  
A) p-acetylphenylalanine, B) p-azidophenylalanine, C) p-propargyloxyphenylalanine,                             
D) p-azophenylphenylalanine, E) o-nitrobenzylcysteine, F) p-benzoylphenylalanine. 
 
These unique functional groups are inserted by using the traditional approaches to 




mutagenic oligonucleotides. The amber codon, TAG is a unique codon and therefore can 
code for the incorporation of a unique functional group. The introduction of unnatural 
amino acids into a protein is by suppression of the nonsense amber codon, TAG.39 
Additionally single or multiple unnatural amino acids can also be incorporated using an 
in vitro approach in response to a 4 base code.40-42 The in vivo approach is what is used in 
the Cropp lab and the technique used in this thesis, so the details of the in vitro approach 
will not be discussed.  
In the genetic code there are 3 stop codons, the amber codon, TAG, is the least 
abundant in all kingdoms of life. To synthesize protein in vivo that contains an unnatural 
amino acid, a unique codon (TAG), an orthogonal tRNA and a cognate aminoacyl-tRNA 
synthetase are required. To incorporate unnatural amino acids into E. coli the 
tRNA/synthetase pair from the archaeal bacteria Methanococcus jannaschii43 is used and 
for eukaryotic organisms the tRNA/synthetase pair is derived from E. coli.44 Structural 
constraints of the tRNA/synthetase pair from an orthogonal organism does not allow for 
any cross-talk with the endogenous system to occur.45 Since in all kingdoms of life the 
amber stop codon, TAG is blank and does not have a tRNA to recognize it, the anticodon 
in the orthogonal tRNA is mutated to CUA to base-pair to UAG, followed by 
randomization of nucleotides to allow for specific incorporation of the unnatural amino 
acid.46 The residues in the active site of the orthogonal synthetase were then mutated by 
directed evolution to accept the unnatural amino acid and charge the tRNA.47 A series of 
in vivo positive and negative selections are then performed on the protein variants to 
remove those that are not orthogonal to the system (negative selection) and enhance those 





Figure 1.5: General method of in vivo incorporation of an unnatural amino acid.  
An unnatural amino acid is inserted as a response to the amber stop codon UAG. An orthogonal synthetase 
charges the mutant orthogonal tRNA with the unnatural amino acid. 
1.4 Disadvantages of traditional protein mutagenesis methods 
The ability to mutate proteins in order to study them has shown to be extremely 
valuable, whether it is to improve protein function in the case of directed evolution, or 
site specifically change codons to alter the chemical reactivity of residues resulting in 
enhanced or deleterious protein function, as well as introducing unique function with 
unnatural amino acids. All the traditional methods to achieve these mutations either 
incorporate multiple random mutations, which might only occur at the DNA level and not 
the protein level, or the ability to site-specifically mutate the coding sequence. There are 
a few disadvantages to these methods, first is that site-directed approaches allow for only 
one mutation to be created at a time and requires a pair of oligonucleotides per desired 
mutation. It would therefore, not be feasible to use this approach in mutating every amino 




identify solvent exposed residues on a protein using thiol protection assays and there was 
little or no information about the tertiary structure of the protein of interest, then the 
codon for cysteine, TGC, would be introduced at every codon position. If the protein of 
interest is 200 amino acids in length, then 400 unique oligonucleotides, 200 PCR 
reactions followed by screening and sequencing multiple clones of the desired mutation 
would be required, as shown in Figure 1.6. So the traditional site-directed approaches are 
only useful if there is previous knowledge of protein structure. 
 
Figure 1.6: Traditional Quikchange mutagenesis depicting incorporating a cysteine.  
If one would want to perform a cysteine scan on the entire protein, 200 individual mutagenesis reactions 
would need to be performed followed by sequencing to verify the mutation. 
 
There are many disadvantages associated with the random approaches, one is 
there is no control over the mutation that is achieved, and since there is redundancy in the 




acids that are in the same row or column of the standard genetic code, Table 1.1. Second, 
several of the random approaches described doe not have control over reading frame, 
which could cause early termination or frame shifts. This dissertation will focus on the 
development of a novel method that incorporates the best aspects of each, randomness 
and the ability for the researcher to choose the mutant codon as well as have a random 
method that allows for a defined number of mutations. 
Table 1.1: Standard genetic code 
 
1.5 Specific Aims 
The aim of this dissertation was to develop a universal random mutagenesis 
method that incorporates a user specified mutation, termed Codon Scanning Mutagenesis 
(CSM). The rational for developing CSM arose while working on incorporating an 
isotopic photoaffinity label, [D11]-p-benzoylphenylalanine (pBpa). Incorporating [D11]-




interaction to be identified by a unique fingerprint in the mass spectra. The isotopic label 
would be useful in the identification of unknown interactions; however this would require 
generating many TAG mutations throughout the gene sequence. It became clear that a 
method was needed which incorporates a specific mutation randomly. An ideal CSM, 
would allow for any mutation to be created, regardless of the nucleotide sequence and 
specifically introduce the mutation in the correct reading frame. Additionally, the use of 
the developed method would allow for the introduction of multiple defined mutations as 
well as, create mutant libraries with a specified percentage of various codons.  
This dissertation is assembled in the order that experiments were conducted and 
the influence that the results provided on future experiments. Described first is the 
incorporation of [D11]-pBpa the conclusions of which inspired the development of a 
novel mutagenesis method that facilitates in-frame codon mutations. The details of the 
components needed to accomplish such a task are then described followed by two proof 
of principal experiments using well characterized targets, 1) glutathione S-transferase 
(GST) for the random incorporation of a photoaffinity label and 2) uracil phosphoribosyl 
transferase (UPRT) in an alanine scan. The specific details of CSM were also optimized 










Chapter 2: In vivo incorporation an isotopic label and the 
limitations of traditional mutagenesis methods 
2.1 Introduction 
As stated in Chapter 1, one of the most useful functions of performing unnatural 
amino acid mutagenesis is the ability to capture two proteins at the interface or trap a 
ligand to the active site. The use of photo-cross-linking amino acids coupled with mass 
spectrometry allows for identification of such interactions to be determined.48-50 
However, this process is limited by the ability to assign an unknown covalent interaction 
in the mass spectra. It has been shown that by incorporating 1:1 mixtures of isotopically 
labeled cross-linking reagents that the indicative isotopic pattern results in the mass 
spectra.48 In an attempt to eliminate this delay in data analysis, it was thought that a 
genetically encoded isotopic label could be introduced into a protein, cross-linking 
initiated with light followed by treating the cross-linked peptides with trypsin and 
analyzing the digested peptides by mass spectrometry for a unique fingerprint.  
The unique fingerprint could arise from the incorporation of an isotopically 
labeled amino acid. The unnatural amino acid p-benzoylphenylalanine has 11 aromatic 
hydrogens. Replacement of all the hydrogens with deuterium would result in an amino 
acid that is 11 atomic mass units larger. The hypothesis being that if incorporated in a 1:1 
mixture with unlabeled, there would be a peak for M and M+11. To test this hypothesis 
the [D11]-pBpa was synthesized and provided by Bryan Wilkins.51 Glutathione S-
transferase was used to test both the incorporation of the labeled amino acid by the 
evolved pBpa synthetase and the ability to identify cross-linked fragments by the unique 
M and M+11 fingerprint. This protein was chosen due to the precedence of cross-linking 




a phenylalanine located at the dimeric interface.53 The advantage of performing cross-
linking experiments by genetically encoding benzophenone is that the side chain of an 
excited benzophenone reacts with adjacent alkyl groups within 4Å. The excited triplet 
state is also short lived and therefore will result in specific cross-linking events to occur. 
Another advantage is that cross-linking is promoted by irradiating the sample with 360 
nm light which does not damage proteins.54 Specific cross-links were also seen in our 
experiments with a genetically encoded isotopically labeled benzophenone. Analysis of 
the mass spectra showed that only the predicted peptides were able to cross-link. 
Scheme 2.1: Reaction of p-Bpa with a methonine side chain. 
 
2.2 Results and Discussion 
In order to incorporate the unnatural amino acid, the gene encoding GST was 




The F51TAG mutation was introduced site-specifically and co-transformed with pSUP-
pBpa,55 a plasmid carrying the orthogonal tRNA/synthathase pair into chemically 
competent E. coli. Expression of both wild-type and F51TAG GST in the presence and 
absence of [D0] and [D11]-pBpa were performed. After a five hour expression, protein 
samples were isolated by Ni-affinity chromatograph and analyzed by SDS-PAGE. Cross-
linking of monomers was initiated by irradiating protein samples in 15 and 30 min 
intervals, Figure 2.1. 
 
Figure 2.1: SDS-PAGE analysis of cross-linking with [D0] and [D11]-pBpa 
Purified protein samples were irradiated with 360 nm light for both 15 and 30 min. Wild-type GST did not 
result in any cross-linking, where as those samples which were expressed in the presence of [D0] and [D11]-
pBpa show ~50-60%  cross-linking. 
 
Samples of the purified products, both cross-linked and un-cross-linked were 
separated by SDS-PAGE. As it can be seen in Figure 2.1, there is a band for the cross 
linked product when either the labeled or unlabeled pBpa added to the media. This 
indicates that the [D11]-pBpa has the same chemical properties and is a substrate for the 
previously evolved aminoacyl-tRNA synthetase. Both monomer and dimer bands were 




analyzed by MALDI-TOF mass spectrometry. Indeed when analyzing the data obtained 
by mass spectrometry the expected, M and M+11 fingerprint could be identified, Figure 
2.2. It was predicated that the fragment carrying the pBpa would give rise to a peak at 
m/z = 2333.2 which corresponds to the fragment 45-FELGLE(pBpa)PNLPYYIDGDVK-
63. However, a peak at m/z = 2460.5 was observed corresponding to the mis-cleaved 
fragment with an additional lysine residue, 44-KFELGLE(pBpa)PNLPYYIDGDVK-63. 
It was also observed in the expression performed in media supplemented with a 1:1 
mixture of [D0] and [D11]-pBpa, a peak at 2460.5 and 2471.4, confirming the hypothesis 
that a unique fingerprint would arise from genetically incorporating an isotopic label. 
Upon, analyzing the mass spectra of the samples which were cross-linked, the unique M 
and M+11 fingerprint was clear, 3028.8 and 3039.5 was observed. The mass difference of 
695.6 (3028.8 – the original peptide, 2333.2) is the exact mass of the peptide of the 






Figure 2.2: MALDI-TOF spectra of GST with [D0] and [D11]-pBpa 
A) Crystal structure of GST (PDB entry 1y6e) with the F51 highlighted in red. This position resides on the 
fragment shown in orange and interacts with the peptide shown in pink (MREDR). B) Each spectra is a 
zoom of the area with the assigned peak. For both monomer (left panel) and dimer (right panel) a double 
appears with two peaks 11 mass units in difference when expressions are done in the presence of a 1:1 mix 





Incorporating [D11]-pBpa shows an M and M+11 fingerprint as expected. Further 
no additional peaks with the signature M and M+11 fingerprint were observed. 
Incorporating genetically encoded isotopic labels should decrease the time commitment 
associated with interpreting mass spectral data. One can envision characterizing protein-
protein or protein-ligand interactions in an unknown system by incorporating a 
photoactive isotopically labeled amino acid. While this appears to be a great advance in 
determining unknown interactions, we are currently limited by methodology used in 
creating the amber codon mutants. If the site of interaction is unknown then multiple 
residues would need to be mutated in order to obtain any significant data. Therefore, a 
general method that incorporates the amber codon, TAG at random codon positions is 
needed. The ability to incorporation of an isotopic label when added to the codon 
mutagenesis method described in this dissertation would be an extremely valuable tool in 
obtaining structural information without the need for NMR or X-ray crystallography. 
 
Figure 2.3: Hypothetical representation of indentifying an unknown interaction 
using [D11]-pBpa 
The topology of an unknown interaction can be identified by the unique M and M+11 fingerprint. 
Incorporation of [D11]-pBpa at multiple sites of one protein (purple) and cross-linking with the red protein 




2.4 Materials and Methods 
Materials. Plasmids pGEX-T4-1 and pBADmycHisA were purchased from GE 
HealthCare and Invitrogen. The plasmid encoding the tRNA/synthethase pair was 
obtained from Peter Schultz (Scripps). The non-labeled amino acid was purchased from 
Bachem and the labeled amino acid was synthesized by Bryan Wilkins.51 All enzymes 
were purchased from New England Biolabs (Ipswich, MA). All reagents used were 
molecular biology grade. 
General Methods. Plasmid DNA was isolated from E. coli using Fermentas 
GeneJet Kit according to the manufactures recommendations. All PCR reactions were 
carried out using a PTC-200 Peltier Thermo cycler. PCR products were purified using 
Qiagen PB buffer. Digested DNA was purified by running DNA on a 1% agarose TAE 
gel, bands excised and DNA purified using Qiagen QG buffer. 
 Cloning of GST and introducing a TAG mutations.  
 
Table 2.1: Oligonucleotides used to incorporate a photo-affinity label 
CL192 CTAGGATCCCCTATACTAGGTTATTGG 
CL310  CCAGTCGACGCCTCTAGAAACCAGATCCGATTT 
CL206  TTGGGTTTGGAGTAGCCCAATCTTCCT 
CL207  AGGAAGATTGGGCTACTCCAAACCCAA 
 
As a preliminary test, the small homodimer, glutathione-S-transferase (GST) was 
chosen. It is known that when Phe51, located at the dimer interface, is mutated to pBpa 
the protein can cross link with the other monomer when irritated with 360 nm light. The 
gene encoding GST was amplified from pGEX-T4-1 (GE Healthcare) using CL192 and 
CL310. The product was purified and digested with BamHI and SalI and cloned into the 
BglII and SalI sites of pBAD-mycHisA (Invitrogen). When expressed, glutathione is 




incorporate the TAG mutation at the Phe51 position standard Quikchange PCR was 
conducted using oligonucleotides CL206 and CL207. The mutation was verified by both 
the lack of the presence of a band on an SDS-PAGE gel as well as sequencing.  
Expression to introduce [D0] and [D11]-pBpa. Expressions were performed by 
inoculating 50 mL of LB medium containing 100 μg mL-1 ampicillin and 35 μg mL-1 
chloramphenicol and grown the presences of 1 mM pBpa (Bachem) or 1 mM pBpa[D11], 
or 0.5 mM pBpa/0.5 mM pBpa[D11] and grown to an OD600 = 0.8. The cultures were 
induced with 0.2% arabinose and expressed for 5 hours. 
Purification and cross-linking. Proteins were then isolated by binding to 
Probond Purification resin (Invitrogen) according to the manufacturer’s protocol for 
native isolation using binding buffer containing imidazole (50 mM NaH2PO4, pH 8.0, 10 
mM imidazole, 0.5 M NaCl). Purified protein (100 μL) was then irradiated with 350 nm 
hand-held 100W Black Ray lamp from a distance of 5 cm at room temperature for both 
15 and 30 min intervals. The cross linked samples were then analyzed by SDS-PAGE.  
Tryptic digests and MALDI-TOF.51 Experiments were performed by Bryan 
Wilkins following an in-gel tryptic digest protocol. Digested samples were then analyzed 
by MALDI using internal standards insulin and insulin oxB. MALDI spectra were 









Chapter 3: A mutagenesis method that is not dependent on 
mutagenic oligonucleotides   
3.1 Introduction 
The previous experiment of incorporating [D11]-pBpa at the dimer interface of 
GST proved that it is possible to characterize transient protein-protein interactions using 
mass spectrometry. It is not feasible to identify unknown interactions by identifying the 
M and M+11 fingerprint. However, if an unknown interaction is too be determined this 
would require the independent generation of many amber codon mutations throughout the 
protein coding sequence with traditional mutagenesis methods, and is therefore a major 
limitation of using the genetically encoded isotopic label. The development of a method 
that can randomly incorporate a specific codon mutation that is not dependent on 
oligonucleotides would be an invaluable tool in creating protein variants and facilitating 
this research. To create random mutations that are codon specific, it was envisioned that a 
target plasmid with the gene of interest could be randomly digested once to create a 
double strand break followed by the removal of three nucleotides and subsequent 
insertion of the specified mutant codon. This approach would lead to a general method 
that allows for scanning a specific codon mutation, see Figure 3.1. Ideally, the codon 





Figure 3.1: Process to randomly mutating a codon position on a library scale. 
To introduce random codon mutations throughout a gene of interest the target plasmid would be randomly 
linearized, followed by the removal of three sequential nucleotides from the coding sequence and ligation 
of the new mutant codon, in this case TAG. This process would create a random single mutation without 
any net addition or deletion of nucleotides.  
 
3.2 Creating a double strand break 
In order to create a codon mutation in the DNA coding sequence, each strand of 
the duplex DNA needs to be broken. An endonuclease that is capable of randomly 
digesting DNA is DNase. As stated earlier DNase has proven to be useful in a variety of 
protein evolution experiments. DNase is used to create multiple random fragments for 
recombining genes as well as to create a single random break in a protein coding 




The use of DNase to introduce the random double stand break was considered. 
Controlling the reaction to only cut once was fairly difficult even when following 
previous reports of using ~1 unit of DNase per mg of DNA and performing the reaction 
at low temperatures, 16 oC for short periods of time. It is also reported that besides for a 
single random cut there are also truncations of the gene as well as nicks in the DNA 
strand.28 In designing a random codon scanning method the use of DNase did not seem to 
be the most reliable option since in many cases unwanted deletions can occur and 
controlling the reaction was difficult. Recently a useful method in targeting DNA once is 
the use of mobile genetic elements, called transposons.  
3.2.1 Transposon Mutagenesis 
Mobile genes were first discovered in maize by Barbara McClintock and are 
responsible for phenotypic differences in the kernels.56 These mobile genetic elements 
have shown to be useful in many areas of molecular biology and genetics, the most 
widely used and best understood is bacteriophage Mu.57 Transposons have been used in 
mapping techniques, DNA sequencing, and to analyze protein-DNA complexes. While 
these mobile genes are found in nature, and therefore is an in vivo process, a protocol has 
been developed that allows for the transposition reaction to occur in vitro with high 
efficiency. The in vivo Mu transposition reaction is fairly complex and requires cofactors 
and accessory proteins.58 The in vitro process has been modified to require the minimum 
components. However, the transposition reaction was not very efficient, since the mobile 
gene was part of a plasmid and required the transposase to cut and paste this element.59 
The most recent in vitro process eliminates the need for the transposase to cut the 




double stranded transposon, where on either end there are recognition sites for the 
transposase including a selectable maker. It is necessary that the ends of the transposon 
are pre-digested with BglII.60 The mechanism of MuA transposon incorporating into 
target DNA is outlined in Figure 3.2. The use of a transposon to introduce random codon 
mutations appears to be a more reliable option, when compared with DNase. There is also 
evidence that this reaction is indeed randomly distributed throughout the target DNA and 
only incorporates once per target.29 Further, there are several commercially available kits 
that use the MuA transposon/transposase or a transposase from the RNase super family 





Figure 3.2: MuA transposon and incorporation into target DNA. 
A) The ends of the transposon are pre-cut by BglII. On either end the recognition sequences are identical 
and there are four nucleotides that do not alter the efficiency of the transposition reaction. B) For the 
transposon to incorporate into target DNA, the transposon is mixed with Hyper MuA transposase. The 
transposase recognizes the target DNA and creates a five base pair staggered cut, at this time there is 
assembly of the transposition complex followed incorporation of the transposon. In vivo DNA repair 
mechanisms will fill in the five base pair gap. The overall process results in a five base pair duplication of 
the target gene at the site of transposon incorporation. 
3.2.2 Deletion of a triplet nucleotide from a protein coding sequence 
There are four base pairs on either end of the MuA transposon that are not 
recognized by the MuA transposase but are incorporated into the final DNA target. This 
sequence can be altered to contain an endonuclease restriction site allowing for the 




mutagenesis to be a useful methodology for pentapeptide scanning. Pentapeptide 
scanning is accomplished by modifying the transposon to have NotI restriction sites 
which are eight bp in length, GCGGCCGC.29 As shown in Figure 3.2, during transposon 
insertion, five base pairs in the target sequence are duplicated,61, 62 as well as the base on 
either end of the transposon that is left over from the pre-cut ends. Transposons have also 
been modified to create libraries of C-terminal deletions, by introducing a series of stop 
codons at the transposon ends.63 
Building on the ability to change the end sequence of a MuA transposon, it was 
shown by Jones that by using a restriction enzyme that cuts outside its recognition 
sequence, type IIS, the result would be a net removal of nucleotides.64 The type IIS 
restriction enzyme that was used is MlyI. The recognition sequence is not a palindrome so 
the direction of which it cuts can be controlled and cuts both strands five base pairs 
downstream of the recognition site. Due to the duplication of base pairs and the 
positioning of the restriction sites, when the transposon is removed from the target DNA 
the result will be a triplet nucleotide removal from the target gene. Triplet nucleotide 





Figure 3.3: MlyI-Mu transposon to remove three nucleotides. 
A) The difference in the ends of the transposon are shown in red, the MlyI recognition sequence is also 
highlighted in red. The mechanism of incorporation of the transposon is the same as in Figure 3.2. B) The 
recognition sites for MlyI are placed so that up to N1 and N5 will be cut resulting in deletion of N2N3N4. The 
gel on the right shows an MlyI digestion of a pool of library clones. 
3.3 Insertion of a new codon 
The use of a modified transposon allows for the removal of three nucleotides and 
sets the stage for replacement of a new codon. Due to the instability of three base pair 
duplex DNA, the mutational codon would need to be part of a selectable phenotype. 
Three nucleotide bases is not enough to remain duplex DNA and therefore T4 DNA 
ligase would not be able to ligate in the codon. The simplest approach to insert a new 




The linker could then have the mutational codon as well as MlyI restriction sites 
appropriately placed on each end.  
 
Figure 3.4: A simple approach to inserting a new codon. 
The pool of randomly linearized N2N3N4 deletion vectors can be ligated with a linker sequence that carries 
the codon to be inserted, TAG. Similar to the MlyI-Mu transposon, the restriction sites are placed so that 
there will be a clean removal of the linker only leaving behind the codon. In this process there would also 
be CTA mutations, as a result of the linker inserting in the reverse direction. 
 
Recently, the triplet nucleotides NNN65 and TAG66 have been randomly 
introduced into a gene using this simple approach. However, only one-sixth of the library 
generated would have the mutation in-frame and the specific codon that is wanted (Figure 
3.5). This is due to the fact that when the transposon is removed, the ends would be blunt 
thus any insert that is ligated can go in both the forward or reverse direction, scanning 
both TAG and CTA. Secondly, the transposon reaction is random and the insertion of a 




method that only facilitates in-frame mutations the linker insertion would have to produce 
a selectable phenotype only when inserted in the correct frame.  
 
Figure 3.5: Insertions of TAG in all 6 frames. 
Only 1 out of 6 insertions will give the correct mutation. The mutational codon, TAG is highlighted in red 
as well as the amino acid mutations that would occur. 
3.4 Development of a reading frame selectable linker 
The most straight forward way to develop a reading frame selectable linker would 
be to not include the promoter in the linker sequence as well as removing the start codon 
from the selectable gene. When the linker is inserted there would be C-terminal 
fusions.67, 68 When designing CSM, the linker would be best if when inserted in-frame 
selection can occur in the presence of an antibiotic selection, such as β-lactamase in the 
presence of ampicillin. A disadvantage of this simple reading frame approach is that the 
possibility that within the target gene there could be several ATG start codons next to 
potential ribosome binding sites.69 The linker would not necessarily have to insert into the 
correct reading frame to give a selectable response and would lead to false positives 
resulting in unwanted out-of-frame mutations. To ensure that mutations would only occur 




The first generation of a reading frame selectable linker was based on a reading 
frame selectable plasmid that was developed by Benkovic and co-workers  for directed 
evolution experiments.70  
 
Figure 3.6: Comparison of C-terminal fusion selection with a “head-tail” selection 
system. 
The left panel displays the traditional C-terminal fusion selection approach. This approach leads to many 
false positives due to possible internal RBS. On the right, the head-tail system requires that a sequence both 
on the N and C termini of the target protein are translated for proper function. Any internal RBS, will 
separate these two components eliminating false positives. 
  
This selection system puts the mutant gene of interest in between a head and tail 
sequence, see figure 3.6. Translation of both the signaling peptide (head sequence) and β-
lactamase (tail sequence) is required for exporting to the periplasm. If any N-terminal 
truncations, as a result of an internal RBS, were to occur then exportation would not 
occur and result in ampicillin sensitivity.  
To test the feasibility of using a head-tail system for the reading frame selection 
the signaling peptide was fused to the target gene. A linker sequence was then created by 
amplifying β-lactamase, without the signaling peptide and start codon. A small scale 
library was created using the Mu-MlyI transposon following the manufactures 




followed by insertion of the linker and selection on ampicillin. After removal of the 
linker sequence several clones were sent to be sequenced. Sequencing results revealed 
that all mutations did in fact occur in the correct reading frame, however all were 
clustered toward the N-terminus of the target gene, Figure 3.6. The bias of the mutations 
favoring the N-terminus of the target gene is caused by the fusion of β-lactamase to the 
target gene and that each protein resulting from the gene fusion would be different, as 
shown in Figure 3.8. 
 
 
Figure 3.7: Position of insertion using a “head-tail” reading frame selection. 
19 individual clones were sequenced, giving 12 different mutation sites. However in a 213 amino acids 
protein, no mutations were found past position 38. 
3.4.1 Incorporating an intein into the selection system 
Incorporating and intein into the selection system would allow for all selectable 
proteins to be the same regardless of where the linker is inserted into the gene. An intein 
is a self splicing protein, similar to introns and exons but occurs after protein translation. 
Inteins excise themselves by either a cleavage or splicing mechanism.71, 72 Two separate 




Generation 2: a non-biased method. The second generation reading frame 
selectable linker that was developed incorporates the use of an intein to minimize the bias 
that was observed with the head-tail selection system. This selection system is based off 
of pInSALect,73 a selection plasmid that addressed the issues that were present in the 
original pSALect70 system. It was found that by simply adding the second layer of 
selection pressure of requiring fusion of the target gene to both a head and tail section 
that is required for proper protein activity was not reliable. A requirement of the selection 
system is that the “head-target protein-tail” fusion is soluble. Protein fusions which are 






Figure 3.8: Comparison of an intein selection vs. a non-intein selection. 
Top panel: Without an intein present, all fusion products will be different lengths. The various gene 
segments that would be introduced between the “head” and “tail” genes could result in proteins that are 
non-functional. Bottom panel: The addition of intein segments on either end of the target gene allow for all 
reporter proteins to be identical. 
 
In the CSM method, the head sequence, tatSS-Nterm-VMA intein is fused to the 
target gene in the target plasmid. The linker sequence includes the C-terminal portion of 
the intein as well as β-lactamase. The restriction sites were placed in such a manner that 
would allow for read through of the fusion gene if inserted in the correct reading frame. 
The initial test of this linker system showed that the bias towards the N-terminus of the 
gene is no longer present. Additionally to test if the reading frame system would still 




introduced and the linker ligated and selected for on carbenicillin. Initially selections 
were done in the presences of ampicillin, however the libraries appeared to be 
contaminated with out-of-frame mutants. This was also the case in the reported 
pInSALect plasmid, where it was hypothesized that ampicillin hydrolysis was the cause 
of obtaining false-positives. Carbenicillin is a more stable analog than ampicillin. 
Selections using the intein system were tested at both 30 and 37 oC and based on counting 
colonies it was confirmed that lower growth temperature resulted in more colonies. 
Lower growth temperatures were also observed in the initial report of pInSALect by 
Lutz.73 
 Figure 3.9 shows the location of the linker as the amino acid position that would 
be mutated. Nine unique locations of the linker were observed out of 12 individual 
colonies. Incorporating the intein into the selection system proved to remove the bias that 
was observed previously. While at first glance the N-terminal bias still seems to be 
present, further sequencing of library of GCG mutants introduced into UPRT, a 217 
amino acid protein, showed mutations to be evenly dispersed as well as a mutation at 





Figure 3.9: Position of insertion using the intein selection system. 
12 individual clones were sequenced and 9 different codon mutations were observed. With the intein 
system the mutations are relatively dispersed throughout the entire sequence when compared with the non-
intein selection system (Figure 3.7). 
 
Generation 3: thymidylate synthase linker. In the initial applications of the 
CSM described in Chapters 4 and 5, fusing the N-terminus of the intein directly to the 
target gene was not ideal. An attractive method would eliminate the need to sub-clone the 
genes which have a single codon mutation into an expression vector. It was also thought 
that CSM should allow for multiple specific mutations to be incorporated. The most 
recent attempts at a reading frame selectable linker is based on a selection system that 
uses an intein thymidylate synthase reporter.75 It has been shown for an intein to catalyze 
excision the N-terminus is not required. Rather then having N-intein-gene-C-intein-
reporter, with a C-terminal cleavage the construct can be assembled gene-C-intein-
reporter.76 To select for ligation events that occur in-frame a thymine deficient strain of 
E. coli was made using the gene knockout method of Wanner, Figure 3.10.77 Through 
homologus recombination, the gene encoding thyA was replaced by a selectable maker, 




survive without media supplemented with thymine or a plasmid expressing thyA, see 
Figure 3.14 in experimental.  
 
Figure 3.10: PCR mediated chromosomal gene knockout. 
A resistance marker is amplified with oligonucleotides that have regions of homology (H1 and H2). This 
segment also carries the FRT sites. The PCR product is transformed with a plasmid carrying the gene for 
λRed recombinase. Through homologus cross over the resistance maker replaces the chromosomal gene. 
The resistance marker can be removed by FLP recombinase that recognizes the FRT sites. 
 
The linker was made by amplifying the intein and thyA from pPPV.75  After many 
attempts of inserting the linker into both a specific site and a library, the ability to survive 
on media not supplemented with thymine could not be recovered. It was hypothesized 
that a sufficient amount of thymidylate synthetase was not produced to survive on media 
lacking thymine which resulted in the cell death. This was tested by first growing ΔthyA 
cells transformed with a library of plasmids with the thyA linker inserted on media 
supplemented with thymine. All colonies resulting from this transformation where then 




frame the cells were able to survive. Since, the ligation of linker and library is blunt and 
an intermolecular ligation event would be rare, a majority of the clones on the plates 
supplemented with thymine would not contain the linker sequence. To remove any 
members of the library that do not contain the linker the initial screen for positive 
insertions would be required. The thyA linker was redesigned to also carry β-lactamase, 
where ampicillin resistance is not dependent on inserting into the correct reading frame. 
The linker can first be ligated into the library, transformed into ΔThyA cells and grown 
on M9 agar supplemented with thymine and ampicillin. Any colonies that survive on 
ampicillin would have the linker inserted. The colonies can then either be pooled and 
dilutions plated or replica plated on M9 agar without thymine. 
This linker eliminates the need to sub-clone the mutant genes into an expression 
plasmid and the only requirements are that the restriction site for MlyI is not present.  
While this linker follows the simple approach to a reading frame selectable linker 
described in 2.4, the possibility of insoluble protein fusions cannot occur due to the 
presences of the intein. The thyA based linker simplifies the CSM process but it is not 
clear if only in-frame mutations will be obtained. In a test, where the linker was site-
specifically placed in-frame and out-of-frame, it was found that the out-of-frame insertion 
was able to survive on media lacking thymine. Upon analyzing the sequence prior to the 
insertion site it was found that there is a start codon and possible ribosome binding site, 





Figure 3.11: Selection using the thyA linker 
A) The thyA linker also carries the gene for ampicillin resistance. Resistance to ampicillin is not dependent 
on inserting in-frame. B) The linker sequence can be ligated with the codon deletion linear library. First the 
library is selected for on media supplemented with both thymine and ampicillin. Next the resulting colonies 
can be replica plated onto media lacking thymine. Only where the linker inserted in-frame will be able to 
survive. C) Sequence of the linker site-specifically inserted in-frame and out-of-frame. The additional base 
for the out-of-frame is highlighted. Although inserted out-of-frame +1, expression of thyA proceeded. 
 
When performing CSM the linker of choice would depend on how clean the 




mutations, the intein-β-lactamase system over the thyA system may be a better choice. 
While fusing the protein of interest to the N-terminus of the intein may render the protein 
inactive, in some cases the protein of interest would still be functional. In the proof of 
concept experiments using CSM, it was found that uracil phosphoribosyl transferase 
(UPRT) was functional when fused to the N-terminus of the VMA intein, as described in 
Chapter 5. While in the first experiment using CSM, sub-cloning of the mutant library 
was required, described in Chapter 4, and in this case the thyA system may have been a 
better choice. The thyA based system may prove to be useful in performing multiple 
scans, as well as, rapidly introduce mutations and screen for desired function by 
performing CSM on an expression plasmid. However, if creating libraries of protein 
variants where the assay for protein function is not performed in E. coil, then sub-cloning 
would be required, regardless of which method is used. 
3.5 Codon Scanning Mutagenesis using a NotI-Mu-transposon 
When working out the specific details of CSM, it was originally thought that 
performing a blunt ligation on library scale would be very inefficient and difficult. And in 
fact, it was found that performing blunt ligations was difficult to obtain the number of 
clones required to cover all possible sites of insertion. Later in the development it was 
found that the inefficiency of the ligation was caused by (1) removing 5’-phosphates 
from the library to inhibit intramolecular ligations and (2) reaction conditions, both the 
ratio of library to linker and the amount of ATP. It was found that the optimal 
concentration of ATP for blunt ligations was 0.5 mM as opposed to the standard 1 mM. 
However, prior to the optimization of the blunt library ligation, details and preliminary 




and performed. The modified transposon has the restriction sites for NotI and is marketed 
for linker scanning mutagenesis. It was originally thought that using the NotI modified 
transposon would be best because a cohesive end ligation would be done rather then blunt 
end ligation in the case of MlyI. The major difference between the two modified 
transposons is that the NotI transposon will leave behind a total of 15 bases, whereas the 
MlyI transposon removes three bases. If using the NotI transposon, the linker needs to be 
designed to remove 18 bases as well as leave behind three for the new codon. A series of 
typeIIS restriction sites are used and would require two digestion-blunting-ligation steps. 
The details of this linker are depicted in Figure 3.12 Either of the reading frame selection 
systems described in section 3.4.1 could also be adapted for the NotI system. 
While using a cohesive end ligation for the linker resulted in more ligation events 
the limitation of processing the linker proved to be problematic. One was digesting with 
BsaXI. It was later found that this enzyme requires two sites to digest DNA efficiently. 
This method also required more processing of the DNA which could lead to unwanted 
mutations from all of the digestion as well as increases the risk of loosing members 
during the various purification steps. It was during this time that the blunt ligation was 






Figure 3.12: CSM using a transposon modified with NotI restriction sites. 
The linear library of vectors is generated by using the commercially available MGS kit from Finnzymes. 
The linker is digested with NotI and ligated with the linker library. To process the mutation, two digestion 
steps are required. The first set, MlyI and BsgI removes the five base pair duplication and replaces a codon 
with the mutation codon (TAG). The second step, BsaXI removes the NotI restriction site. 
3.6 Development of a transposon that can create random in-frame codon mutations 
While developing the reading frame selectable linker, it was thought that the 
transposon can be used to randomly delete in-frame-codons. If the modified MuA 
transposon can delete three nucleotides at random and in-frame mutations can be chosen 




response can be the inserted between the two recognition sites of the transposon. This 
was worked out using the intein-β-lactamase system and the pIT-target. Using CL826 
and CL827 the C-terminus VMA intein and β-lactamase were amplified from 
pIntSALect. The oligonucleotides were designed with the five base pair duplication of 
the reaction in mind and when inserted in-frame there would be translation throughout 
the recognition sequence. The transposition reaction conditions were performed 
according to the manufactures recommendations. Transposon insertions were selected for 
on LB agar that was supplemented with kanamycin and carbenicillin and compared to 
media only supplemented with kanamycin to determine transposition frequency. By 
sequencing individual clones, it was found that the transposon did in fact insert in-frame 
and removal of the transposon results in an in-frame codon deletion. The properties of 
this in-frame deletion transposon are currently being used by Jia Liu, who is expanding 
on the developed CSM method.  
3.7 Overall process of CSM and the determination of sufficient library coverage 
In the following experiments described in Chapters 4 and 5 the reading frame 
selection system that was used for CSM is based off of the intein based “head-tail” 
system described by Lutz and coworkers.73 An outline of the method is depicted in Figure 
3.13. The following equation for estimating the number of clones needed to determine if 
sufficient library coverage was obtained was used:78 
Equation 3.1: )1ln( FVL −−=  
 
Where L is the number of clones in the library, V is the number of variants and F is the 
percent confidence. In the example in Figure 3.13, the number of clones to ensure 99% 




size of the resistance marker and origin of replication are subtracted from the overall size 
of the plasmid. Approximately 10,000 clones would be required for complete library 
coverage. 
000,10~)99.01ln(2100 =−−=L  
 The number of clones required for ligation of the linker followed by selection on 
carbenicillin for the correct reading frame is far less. If the target gene is 600 bp then 
there are 200 possible codons to mutate. Using equation 3.1, approximately 930 clones 
would be required to ensure that complete library diversity is maintained. 





Figure 3.13: Overall process of CSM. 
pIT target plasmid: tatSS (pink) and N-term intein (orange) is fused to the target gene (green). Insertion of 
the transposon should yield ~10,000 colonies. This library can be further purified by removing the target 
gene with the transposon inserted and ligating with the original plasmid backbone. Removal of the 
transposon by MlyI removes N2N3N4. Ligation of the linker with C-term intein (light orange) and β-
lactames (blue) and selection on carbenicillin should yield ~930 colonies. Digestion with MlyI leaves the 




3.8 Materials and Methods 
Materials. All restriction enzymes, Phusion Polymerase and T4 DNA ligase were 
purchased from either New England Biolabs (Ipswich, MA) or Fermentas (Glen Burnie, 
MD). MuA transposase was purchased from Finnzymes (Finland). Oligonucleotides were 
synthesized by both Integrated DNA Technologies, Inc. (Coralville, IA) and Invitrogen 
(Carlsbad, CA). The plasmid pInSALect was obtained from Stefan Lutz, Emory 
University and pPPV from Michael Hecht, Princeton University. DNA sequencing was 
done by University of Michigan DNA Sequencing Core. Antibiotics; kanamycin, 
ampicillin, carbenicillin were purchased from Fisher. Chemical competent Gene Hogs 
were used in all experiments except were noted.  
General Methods. Plasmid DNA was isolated from E. coli using Fermentas 
GeneJet Kit, Zymo Research Zyppy Plasmid Miniprep kit, or Qiagen Plasmid Midi prep 
kit according to the manufactures recommendations. All PCR reactions were carried out 
using a PTC-200 Pelteir Thermo cycler. PCR products were purified using Qiagen PB 
buffer. Digested DNA was purified by running DNA on a 1% agarose TAE gel, bands 
excised and DNA purified using either Qiagen QG buffer or via electroelution followed 
by isopropanol precipitation. 
Table 3.1: Oligonucleotides used for constructing the components used for CSM 
CL266  GCTTAGATCTGACTCGGCGCACGAAAAACGCGAAAG 
CL861  GGATCGACTCTCCTGGGTATTCGCAATAATCTTAATACTGAG 
CL863  CTAGATCTGACTCAATTACCAATGCTTAATCAGTGAGGCACCTA 
CL1064 AAGAGTCGAACAGCGAGAAGAGCAAATTCGAGCTCGAACAAC 
CL1065  AAGAGTCTGCAACGCTGAAGAGCTTCTAGATACGTAAGATCTTTACA
  CCGCCATC 
CL1066 AAACCAGATCTGACGAAAGGGCCTCG 





MlyI-Mu transposon. The MlyI transposon was created by PCR amplifying the 
Entranceposon (M1-CamR) (Finnzymes) with CL266 to incorporate MlyI restriction 
sites. The 1254 bp product was phenol-chlorofom extracted followed by ethanol 
precipitation. The purified product was then digested with BglII for 3 hours, phenol-
chloroform extracted and ethanol precipitated. The DNA pellet was re-suspended in 50 
μL of water and quantified by gel electrophoresis. Later in the development of the 
method the transposon was cloned into the SmaI site of pUC18 to allow for higher 
quantities of the pre-cut transposon to be produced. 
ThyA gene knockout. To delete the gene encoding thymidylate synthase from 
the genome of E. coli the PCR based gene knockout method that was described by 
Datsenko and Wanner.77 Oligonucleotides CL50 and CL51 were designed to amplify the 
kanamycin resistance gene from pKD13.77 Flanking the kanamycin resistance gene is a 
36 nucleotide homology with the sequence that flanks the sequence on either side of the 
genomic thyA gene. PCR gave a 1400 bp band which was purified by ethanol 
precipitation. The amplification of the resistance gene also carries FLP recognition target 
sites. Gene Hogs were then transformed with pKD46 which carries the gene for λ-Red 
recombinase. 4 mL of LB supplemented with 100 μg mL-1 ampicillin was added after a 
one hour recovery. Once the culture reached saturation the 5 mL’s was added to 250 mL 
2XYT supplemented with 100 μg mL-1 ampicillin and grown at 30 oC until the culture 
reached OD600 = 0.3. At that time 10 mM of L-arabinose was added to begin expression 
of λRed recombinase. The culture was grown to OD600 = 0.6 then washed with cold 
water and electroporated with the kanamycin PCR product. 1 mL 2XYT was added to the 




plated, the remainder 750 μL was recovered for 7 hours then plated on M9 media 
supplemented with thymine and kanamycin. Individual clones were then picked and 
replica plated on M9 media supplemented with thymine and trimethoprim. Selection on 
trimethoprim eliminates any clones which have functional ThyA.79 A single clone which 
survives the selection is then grown in media supplemented with thymine. The now 
kanamycin resistant, thyA deletion strain is made competent and transformed with pCP20 
a plasmid carries FLP recombinase and recognizes the FRT-flanked resistance gene.80 
Colonies which are sensitive to all antibiotics and can survive on media supplemented 
with thymine and thymine and trimethoprim were colony PCR amplified and the product 
sequenced to show that the expected scar remains. Figure 3.14 compares Gene Hogs and 
the ΔthyA deletion strain carrying pUC18 an ampicillin resistant plasmid. The plates 
show that the strain can survive on M9 media in the presence of thymine (D) and 
trimethoprim, (C) whereas Gene Hogs are not able to survive on trimethoprim (B and C). 
Additionally there is zero growth of the thyA deletion strain on media that lacks thymine 






Figure 3.14: Growth of the ΔthyA strain. 
All plates are M9 media supplemented with 100 μg mL-1 ampicillin (A) no additional additives, (B) 10 μg 





Chapter 4: Scanning photoaffinity mutagenesis 
4.1 Introduction 
The first protein that was chosen to test the developed CSM method was 
glutathione S-transferase (GST) from Schistosoma japonicum. This protein was picked 
because it is a small protein, 219 amino acids and is a well characterized homo-dimer.52, 
53 Another unique feature is that when a photo-reactive amino acid is placed at the 
interface cross-linking can occur.36 This then shows that CSM is useful in scanning 
unnatural amino acids throughout a protein coding sequence. From preliminary tests with 
the linkers it was decided at the time to use the intein-β-lactamase linker and target 
plasmid that were both derived from pInSALect.73 The gene encoding GST was 
amplified and cloned into pIT, so that GST would be fused to the N-terminus of the 
intein. 
4.2 Results and Discussion 
4.2.1 Generation of an amber codon-scanned library of the gene encoding 
glutathione S-transferase 
Using the MlyI-Mu transposon a library of >104 independent colonies was 
generated.81 This library was further purified by digesting to pool all GST target genes 
containing the transposon and religating with the vector. Removal of the transposon with 
MlyI results in deleting three nucleotides. The linker that was used has a TAG codon and 
when inserted in the correct reading frame a selectable phenotype is produced. When this 
library was plated in both the presence and absence of carbenicillin, it was observed that 




library (83.3%). Removal of the linker leaves TAG in place of the three nucleotides that 
were removed when the transposon was excised.  
 
Figure 4.1: Process of using CSM to create random TAG mutants in GST. 
The target plasmid, pIT-GST is used in a transposition reaction where successful insertions are screened on 
kanamycin (resistance of target plasmid) and chloramphenicol (resistance of transposon). Based on the size 
of the target plasmid it was estimated that 11,600 clones are required for 99% library coverage (using 
equation 3.1). The gene encoding GST is 699 bp, there are only 233 positions where the linker can insert in 
the correct reading frame and for 99% confidence 1,100 clones are required. In both cases the clones 
obtained were sufficient for full library covrage. 
 
While processing the library an individual clone from the linker ligation was 
removed and processed separately. Based on the insertion site of the linker the sequence 
of the transposon clone was determined. Digestion with MlyI followed by ligation yielded 
the expected TAG mutation, Figure 4.2. The sequencing represents a single event that is 






Figure 4.2: Sequence of a single clone through each step of CSM.  
In the wild-type sequence the ACA that will be mutated is highlighted. The removal of the ACA codon is 
shown by the site of the MlyI-transposon (no sequence data available). Next is the insertion site of the MlyI 
linker, and cut sites are indicated by red arrows. Last is the final sequence showing the TAG mutation in 
place of ACA. 
 
4.2.2 Expression and purification of random TAG GST mutants 
Removal of the linker generated thousands of clones, where each member 
presumably would contain the expected mutation seen in Figure 4.2. Ten representative 
TAG-GST mutants were chosen at random and cloned into the expression plasmid 
pBADmycHisA and transformed into E. coli expressing the translational components for 




individually grown and expressed with or without pBpa present. Resulting mutant 
proteins were isolated by Ni2+ resin purification and analyzed by SDS-PAGE, Figure 4.3. 
 
Figure 4.3: SDS-PAGE analysis of 10 amber mutants. 
Expressions were done in the absence (-) and presence (+) of pBpa. All mutants expressed, except for 
L64TAG. 
4.3 Conclusions 
As it can be seen in Figure 4.3, only when the culture was supplemented with 
unnatural amino acid the protein was expressed and purified. Not all mutants expressed 
the same level of protein, and one clone (L64TAG) did not produce any protein even 
after multiple attempts. We believe that the inconsistency in the amount of protein 
produced is based on the context effects of amber suppression. Only mutants which 
showed good expression with pBpa were irradiated with 365 nm light and loaded onto an 
SDS-PAGE gel to analyze if a covalent bond had formed across the dimeric interface, 
Figure 4.4. The only mutant that showed minor cross-linking is P85TAG. When the 
positions of the mutants are referenced on the crystal structure of GST, it can be seen that 





Figure 4.4: Location and photo-activity of amber mutants 
The location of each of the mutations (red) was identified in the crystal structure (PDB 1Y6E). Mutants 
which produced the greatest amount of protein were irradiated with 360 nm light to promote cross-linking. 
The known cross-linking mutation F51TAG was used as a control.  
 
Although only 10 individual clones were analyzed in the initial test of CSM, those 
10 only represented a small fraction of the clones obtained. The use of the method of 
scanning a photo-cross-linking amino acid throughout a protein would allow for 
unknown interactions to be found. It would be possible to express the pool of mutants 
with the [D11]-pBpa, described in Chapter 2 and analyzed by mass spectrometry or 
individuals can be expressed spatially separated and purified in a high-throughput manner 




4.3.1 Unexpected mutations and possible causes 
In this first experiment using the developed CSM method, 48 TAG mutants were 
sequenced. Of the 48 sequenced it was found that only 15 different clones had the correct 
TAG mutation. Other mutations included either an addition or deletion of a codon before 
the mutation, see Figure 4.5. There were also unexpected mutations where an additional 
base was removed, either part of the coding sequence or the T and G of the scanned TAG 
codon. It was also found that some did not have a TAG mutation but instead were 
missing between 2 and 6 in-frame nucleotides. After analyzing the sequence data it was 
determined that majority of the unexpected mutations were caused by mis-cutting of 
MlyI, which could have been caused by either long reaction times or inappropriate 
reaction conditions. It is not believed this is caused by star activity, MlyI is a dimer and 
proper cutting requires that both dimers reach exactly 5 bases (NEB, personal 
conversation).  The mis-cutting of MlyI, can cause the addition or deletion of a codon 
before the mutation, as well as the removal of the first base of the mutational codon as 
well as the 2 to 6 in-frame deletions, shown in Figure 4.5. The result of the last base 
missing from the mutational codon is caused by oligonucleotide synthesis. 
Oligonucleotides are synthesized from 3’ to 5’ and with standard desalting ~30% that are 
either lacking the 5’ base or a deletion within the oligonucleotide (IDT, FAQ website, 
and personal conversation with representatives). It was found that even with additional 
purification the last base was missing from the mutational codon. These unexpected 






Figure 4.5: Unexpected mutations from CSM 
The unexpected mutations that were identified from sequencing include (a) an additional codon or (b) 
deletion of a codon. As well those which had a TAG, but were missing and additional base (c and d). And 
several which did not have a TAG present but were missing (e) 2 bp, (f) 3 bp, (g) 4 bp and (h) 6 bp. There 




4.4 Materials and Methods 
Materials. All restriction enzymes, Phusion Polymerase and T4 DNA ligase were 
purchased from either New England Biolabs (Ipswich, MA) or Fermentas (Glen Burnie, 
MD). MuA transposase was purchased from Finnzymes (Finland). Oligonucleotides were 
synthesized by both Integrated DNA Technologies, Inc. (Coralville, IA) and Invitrogen 
(Carlsbad, CA). The plasmid pInSALect was obtained from Stefan Lutz, Emory 
University. Plasmids pGEX-T4-1 and pBADmycHisA were purchased from GE 
HealthCare Life Sciences and Invitrogen. DNA sequencing was done by University of 
Michigan DNA Sequencing Core. All media and antibiotics were molecular biology 
grade. Chemical competent Gene Hogs (Invitrogen) were used in all experiments. 
General Procedures. Plasmid DNA was isolated from E. coli using Fermentas 
GeneJet Kit, Zymo Research Zyppy Plasmid Miniprep kit, or Qiagen Plasmid Midi prep 
kit according to the manufactures recommendations. All PCR reactions were carried out 
using a PTC-200 Pelteir Thermo cycler. PCR products were purified using Qiagen PB 
buffer. Digested DNA was purified by running DNA on a 1% agarose TAE gel, bands 
excised and DNA purified using either Qiagen QG buffer or via electroelution followed 
by isopropanol precipitation. 
Table 4.1: Oligonucleotides used in photo-affinity mutagenesis 
CL502 GTCTAGATCTCCCCGCGCGTTGGCCG 
CL227  ATGTATATCTCCTTGAAATTGTTATCCGCTCAC 
CL273 TTTCAAGGAGATATACATATGAACAATAACGATCTCTTTCAGGACTCA 
  CGTCGGCGTTTT 
CL276  CTCGAGGCCTCTAGAGAATTCGGATCCGGCCATGGTACCTCTGACAAC
  TTTAGAGTACAA 
CL192  CTAGGATCCCCTATACTAGGTTATTGG 
CL310  CCAGTCGACGCCTCTAGAAACCAGATCCGATTT 
CL195 TATCGTCTTGAATCCAACCCGGTA 





CL198  GTCTGCGATTCCTACTCGTCCAACAT 
CL665  GTCGTTCAGAAAAGTCAGCACAGAGCCCACAAAAGTGATTCAAGTCG 
CL666  CGACTTGAATCACTTTTGTGGGCTCTGTGCTGACTTTTCTGAACGAC 
 
pIT-GST construction. Plasmid pIT-GST contains that Tat-signal sequence, the 
N-terminal portion of the cis-splicing VMA intein and glutathione S-transferase from 
Schistosoma japonicum. All three genes are in-frame fusions expressed from a lacP 
promoter. pIT-GST was generated by amplifying the lacP promoter from pUC19 using 
oligonucleotides CL502 and CL227 and gel purifying the 200 bp product. The Tat-signal 
sequence and N-terminal portion of the VMA intein was amplified from pInSALect using 
oligonucleotides CL273 and CL276, producing a 998 bp product which was then gel 
purified. Each product was then used in an overlap PCR with CL502 and CL276. The 
1141 bp product was then digested with BglII and EcoRI and inserted into the BamHI and 
EcoRI sites of pKQ. The GST gene was then amplified from pGEX-T4-1 using 
oligonucleotides CL192 and CL310 resulting in a 675 bp product which was gel purified 
and digested with BamHI and SalI and inserted into the BamHI and SalI sites of pIT. 
Several restriction sites were then removed by Quikchange mutagenesis. One located in 
the origin of replication, which was removed using CL195 and CL196, one in the 
kanamycin resistance marker using CL197 and CL198 and another in the intein using 
CL665 and CL666. 
Deleting a triplet nucleotide. To create the randomly TAG codon scanned 
library, the target plasmid, pIT-GST was used in an in vitro transposon mutagenesis 
reaction. In a 20 μl reaction, 400 ng of target plasmid was mixed with a 1.3 molar excess 




DNA 2 μL of 10X HyperMu reaction buffer (1.5 M potassium acetate, 0.5 M Tris-acetate 
(pH 7.5), 0.1 M magnesium acetate and 40 mM spermidine) and 1 μL of Mu transposase 
(Epicenter) was added. The reaction was then incubated at 30 oC for 4 hours and stopped 
by adding SDS to a final concentration of 0.1% (w/v) and heating the reaction to 75 oC 
for 10 min. The reaction was then placed on ice and 4 μL was transformed into 200 μL of 
chemically competent E. coli and recovered in 1 mL SOC for 1 h at 37 oC. Freshly 
transformed E. coli were then plated on LB agar supplemented with 50 μg mL-1 
kanamycin and 10 μg mL-1 chloramphenicol and grown at 37 oC. The next day there were 
~17,000 chloramphenicol resistant colonies and it was determined that that the efficiency 
of the transposition reaction was ~2.5% when compared with plates that only contain 
kanamycin.  
Ten individual colonies were picked and analyzed by restriction digest. It was 
determined that the reaction was indeed random, however due to the large size of the 
plasmid a large percentage of the library contained the transposon not in the target gene, 
GST. To purify the library, all colonies were pooled and plasmid DNA isolated. Members 
of the library that contain the transposon in GST were isolated by digestion with BamHI 
and SalI, which gave 4 bands: pIT backbone + transposon, pIT backbone, GST + 
transposon and GST. The bands for the pIT backbone and GST + transposon were 
isolated by gel electrophoresis, relegated and transformed into chemically competent E. 
coli, recovered in 4 mL SOC for 1 hour and the plated on LB agar supplemented with 50 
μg mL-1 kanamycin and 10 μg ml-1 chloramphenicol and grown at 37 oC. This 




restriction digest showing that all members have the transposon in the GST gene. All 
clones were then pooled and plasmid DNA isolated. 
Inserting the TAG-intein-β-lactamase linker. The transposon library was then 
digested with MlyI to remove the transposon and random three nucleotides. The 
randomly linearized library was then ligated overnight with the second generation 
reading frame selectable linker (see 2.4.2) that contains the TAG codon. The ligation was 
performed in a 1:5 library to linker ratio, with a decrease in ATP concentration from 1 
mM to 0.5 mM as recommended for blunt ligations. All 20 μL of the ligation was then 
transformed by adding 800 μL of chemically competent E. coli and recovering in 4 mL 
SOC for 1 hour at 37 oC. The transformed ligation was then plated on LB agar 
supplemented with 50 μg mL-1 kanamycin and 40 μg mL-1 carbenicillin. At this state the 
plates were grown at 30 oC, which was found to be a critical step for intein-mediated 
splicing. The library resulted in 1635 kanamycin and carbenicillin resistant colonies. The 
library was then pooled and plasmid DNA isolated and the linker removed by MlyI 
digestion to leave behind the TAG codon scar. The digested library was gel-extracted and 
ligated at low concentrations at room temperature for 2 h. The mutant library ligation was 
then transformed by mixing 5 μL of the ligation reaction with 200 μL of chemically 
competent E. coli, recovered in 1 mL SOC for 1 h and plated on LB agar supplemented 
with 50 μg mL-1 kanamycin and grown at 37 oC, which resulted in >40,000 individual 
colonies. From the library, 48 individual colonies were chosen to be sequenced, of which 
10 were chosen as representatives of the library and expressed in the presence of the 





Expression and Purification. The ten representative clones were each digested 
with BamHI and SalI to remove the TAG mutant gene and inserted into the BglII and SalI 
sites of the expression plasmid pBADmycHisA (Invitrogen). Each of the ligations was 
then transformed into chemically competent Gene Hogs that contained the plasmid 
pSUP-pBpa. All expressions were done on a 50 mL sale in LB media, 50 μg mL-1 
ampicillin, 30 μg mL-1 chloramphenicol and supplemented with 20 mM pBpa (racemic). 
All individual clones were expressed in both the presence and absence of amino acid. All 
cultures were grown to OD600 = ~0.5-0.6 then induced with 0.04% arabinose and grown 
for an additional 6 hours at 37 oC.  
Mutant proteins with or without pBpa were then purified by centrifuging each 
culture to pellet cells and resuspending in 2 mL of native binding buffer (100 mM 
HEPES, 10 mM imidazole, 1 mM PMSF). Cells were lysed by sonication (3 min, 10 s on, 
10 sec off) and then centrifuged at 13,000 rpm for 20 min to clear the lysate. To the 
cleared lysate 100 μL of 50% slurry mix of Promega HisLink resin was added. The resin 
and lysate were incubated on ice for 30 min with mixing. The resin was washed twice 
with 1.5 mL of wash buffer (100 mM HEPES, 50 mM imidazole) followed by elution 
with 200 μL of elution buffer (100 mM HEPES, 500 mM imidazole). A fraction of each 
of the purified mutants there were expressed in the presences of pBpa were then 




Chapter 5: Codon Scanning Mutagenesis to identify residues 
essential for catalysis 
5.1 Introduction 
Several unwanted and unexpected mutations were observed after scanning p-
benzoylphenylalanine through glutathione S-transferase using the developed CSM 
method. It was thought that to address these issues, a well characterized protein that has a 
simple assay would be ideal. The protein uracil phosphoribosyl transferase (UPRT) was 
chosen due to the size of the protein, availability of a crystal structure (Lokanath, N.K., 
unpublished) and the ease of the assay to select for either functional or non-functional 
mutants. To prove the versatility of the developed CSM method, a linker carrying the 
alanine codon GCG will be used to generate a library of UPRT having randomly placed 
in-frame single GCG codon mutations. In many examples of determining active site 
residues, alanine is a common choice, due to the size and un-reactivity of the side chain. 
Previous work on introducing a mutation in the active site of UPRT resulted in a variant 
with a decreased activity. It was expected that the results of an alanine scan on UPRT, 
followed by a high-throughput assay and sequencing would show that any residue either 
located in the active site or essential for folding would decrease the catalytic activity. 
UPRT is involved in the salvage pathway for nucleotide synthesis. All 
phosphoribosyltransferases catalyze the transfer of the 5-phosphribosyl from 5’-
phosphoribosyl-α-1-diphosphate to a nitrogenous base. The salvage pathway for 
nucleotide biosynthesis recycles free bases from the breakdown of nucleic acids. UPRT 




then is converted to dUMP. dUMP is the precursor to dTMP which is catalyzed by 
thymidylate synthase.    
Scheme 5.1: Conversion of uracil to uridine monophosphate by UPRT  
 
 
To assay the mutant UPRT the pro-toxin 5-flurouracil is used. With functional 
UPRTase, 5-flurouracil is converted to 5-fluoro-dUMP, which is a substrate for 
thymidylate synthase. 5-fluoro-dUMP inhibits and inactivates thymidylate synthase by 
forming covalent complex to both the enzyme and tetrahydrofolate which would inhibit 
thymine synthesis and result in cell death. Since UPRT is endogenous to E. coli a strain 
that has a deleted open reading frame of genomic UPRT (GH371) is used. 
Alanine mutations were introduced into E. coli UPRT using CSM. The mutant 
library was transformed into the GH371 strain of E. coli. When plated in the presence of 
5-flurouracil any mutants that are active should not be able to survive. Those which are 
able to survive would have either a mutation that does not allow for proper folding or a 
mutation in the active site that would not allow for the conversion of 5-flurouracil to 5-






Scheme 5.2: Conversion of dUMP to dTMP. 
 
A) Conversion of dUMP to dTMP by thymidylate synthase. B) 5-fluoro-dUMP inhibits is an irreversible 
inhibitor of thymydylate synthase by remaining covalently bound to both the Cys residue in the active site 




5.2 Results and Discussion 
 
Figure 5.1: Process of using CSM to create random GCG mutations in UPP. 
The target plasmid pIT-UPP (purple) is used in a transposition reaction where ~16,000 colonies were 
obtained where 10,000 were required for 99% library coverage. Removal of the transposon and insertion of 
the linker followed by selection on carbenicillin yielded greater then 10 times the number required for 99% 
confidence that all possible mutations were created. After the selection for reading the linker was removed 
and 96 individual clones containing a GCG codon mutation were picked, assayed for function and 
sequenced. 
 
5.2.1 Addressing the unexpected mutations 
Use of a high fidelity MlyI. While there were many unexpected mutations that 
were observed all but one example were due to the mis-cutting of MlyI. Suppliers of 
restriction enzymes are now offering high-fidelity versions of many of the enzymes. The 
fast-digest MlyI (SchI) from Fermentas claims to have buffer optimization that results in 




with MlyI, it was found that both the addition and deletion of additional nucleotides was 
no longer a problem and that as expected only three nucleotides were removed. Using a 
high fidelity enzyme eliminated the unexpected mutations that were observed previously 
in Figure 4.5 a-h. 
Redesigning the linker. To address the problem were the last nucleobase of the 
mutational codon was missing, the linker was redesigned such that the blunt ends are 
generated by releasing the linker from a plasmid by MlyI digestion. This ensures that the 
linker is blunt, contains all nucleobases for the mutational codon as well has being 
phosphorylated. Since MlyI is needed to release the linker from a plasmid used for 
replication, a different restriction endonuclease is needed to leave behind the mutational 
codon in the target gene. Like MlyI the restriction enzyme used to release the linker and 
leave the mutation would need to be a type II restriction endonuclease. It would have 
been ideal to have an enzyme that cuts blunt, however MlyI is the only known enzyme 
that has this activity. Other type IIS endonucleases cut out side the recognition sequence 
but will leave overhangs, which would then require another step in the process to blunt 
the ends. The appeal of SapI, is that the enzyme leaves a three base pair overhang. The 
new linker was designed so that on both ends there is the mutational codon, upon 
digestion with SapI, the two three base pair sticky ends will be complementary to each 
other and will be the mutational codon. This method also elevates the possibility of SapI 
mis-cutting and removing extra nucleotides, if the two ends are not identical then a 
ligation event will not take place. The limitation of the SapI linker is the ability to scan 
the amber codon TAG throughout a gene is slightly more complicated and would require 




a plasmid that has the orthogonal tRNA-synthetase pair but incorporates an endogenous 
amino acid. 
 
Figure 5.2: Reading frame linker with SapI sites. 
Sequencing of an individual clone shows that it is inserted in-frame and has the codon GCG on either end. 
Digestion of SapI leaves a three base pair overhang. The overhang is the mutational codon, GCG. 
5.2.2 Introducing random GCG mutations into the gene encoding UPRT 
CSM was performed as previously described in Chapter 4, using the redesigned 
SapI linker. The reaction with the MlyI transposon gave >16,000 clones, consistent with 
the TAG-GST library. Through each step of the process, linker insertion and removal, the 
number of clones required to ensure that every position has been targeted was obtained. 
The linker insertion resulted in thousands of colonies and removal to generate the GCG 




were chosen to be analyzed for functional UPRT in the presence of 5-FU. The results of 
the selection can be seen in Figure 5.2 and Table 5.1. 
  
 
Figure 5.3: Assay of Ala UPRT mutants in the presence of 5 FU.  





Table 5.1: Survival of alanine UPRT mutants on 5-FU 
 




5.2.3 Analysis of alanine mutations 
Sequencing of the 96 alanine scanned UPRT clones confirmed that the undesired 
mutations that were observed in the GST library were caused by both MlyI mis-cutting 
and the purity of the oligonucleotides. Of the 96 individual clones sent for sequencing 
only 27 were unreadable. Of the 69, only 1 was missing the last G of the GCG codon. 
There were 22 different mutations found out of 64 clones, the other 4 clones were wild-
type UPRT, there are nine GCG codons in the wild-type sequence. The mutations were 
then corresponded to the ability to survive on 5-FU and location in the protein crystal 
structure.  
Majority of the detrimental alanine mutations make sense based on the location 
within the crystal structure. An interesting result is the Pro131Ala, in previous studies it 
was determined that this residue was necessary for enzymatic activity. When Pro131 was 
mutated to Asp there was a decrease in activity by 50-60 fold.2 However in the assay 
performed on the randomly selected mutants, one of which has the catalytic proline 
mutated to alanine and an assay on 5-FU confirms that this mutant is still functional. This 
may also explain why there were not many detrimental mutations found in the library. 
Even if small amounts of 5-FU is being converted to 5-F-dUMP that is still enough to 
bind and inhibit thymidylate synthase. Of the clones that were able to survive on high 
concentrations of 5-FU, two were arginines, R28A and R112A. Each of these could be 
responsible for multiple hydrogen bond interactions and would contribute the overall 
tertiary structure. The other three were leucine mutations, L19A, L97A, L142A. L142A 
is located in the active site of UPRT, the others are located in hydrophobic regions, L19A 
may be interrupting interactions between the two monomers, shown in purple and yellow 




water molecules to be present disrupting the other structure. It was surprising to find that 
all of the clones with a Pro to Ala were unable to survive on concentrations greater then 1 
μg mL-1 5-FU. One would have thought that these mutations would have been 
detrimental to protein folding, rendering the enzyme inactive. However, to conclusively 
say that particular residues are essential for enzyme activity, further purification and 
assays would need to be conducted. The 5-FU assay that was performed, Figure 5.1, 
appears to not be consistent for all mutants. For instance the P119A variant was found 14 
times, see Table 5.1, three of which survive up to 8 μg mL-1 5-FU and the others between 
0 and 0.5 μg mL-1 5-FU. It is possible that those mutants which can survive on drastically 
different amounts of 5-FU, are producing protein at different rates. To determine if this is 
the case, the mutants should be expressed from an inducible promoter and measure the 
amount of protein produced by SDS-PAGE. Interestingly, Q194A, had little effect on 
UPRT, whereas arginine mutations seem to inactive UPRT.  
5.3 Conclusions 
In conclusion the changes made to CSM, using a high fidelity MlyI and 
redesigning the linker appear to have minimized unexpected mutations. Ideally further 
experiments need to be done on mutants obtained from CSM. A similar experiment that 
was performed by Jensen that identified the P131 residue as being essential in activity2 
could be done all the mutants obtained that were able to survive on high concentrations of 
5-FU. However, we were more interested in optimizing the method then obtaining data 
on UPRT. This proof of concept experiment has also proved that CSM will be useful in 
obtaining preliminary enzymatic data. A slight disadvantage to this developed method is 






Figure 5.4: Location of Ala mutants in UPRT. 
Highlighted in teal is the active site residues of UPRT. Top right panel highlights the position of mutation 




5.4 Materials and Methods 
Materials. All restriction enzymes, Phusion Polymerase and T4 DNA ligase were 
purchased from either New England Biolabs (Ipswich, MA) or Fermentas (Glen Burnie, 
MD). MuA transposase was purchased from Finnzymes (Finland). Oligonucleotides were 
synthesized by both Integrated DNA Technologies, Inc. (Coralville, IA) and Invitrogen 
(Carlsbad, CA). The plasmid pInSALect was obtained from Stefan Lutz, Emory 
University. Plasmids pGEX-T4-1 and pBADmycHisA were purchased from GE 
HealthCare Life Sciences and Invitrogen. DNA sequencing was done by University of 
Michigan DNA Sequencing Core. All media and antibiotics were molecular biology 
grade. Chemical competent Gene Hogs were used in all experiments. 
General Procedures. Plasmid DNA was isolated from E. coli using Fermentas 
GeneJet Kit, Zymo Research Zyppy Plasmid Miniprep kit, or Qiagen Plasmid Midi prep 
kit according to the manufactures recommendations. All PCR reactions were carried out 
using a PTC-200 Pelteir Thermo cycler. PCR products were purified using Qiagen PB 
buffer. Digested DNA was purified by running DNA on a 1% agarose TAE gel, bands 
excised and DNA purified using either Qiagen QG buffer or via electroelution followed 
by isopropanol precipitation. 
Table 5.2: Oligonucleotides used in CSM to identify critical residues in UPRT 
CL1008  AAAGGATCCCATATGAACAGTTTTGGCAACTTG 
CL834  AAAAGAATTCTGCT TTTCTTCGCGAATTAATTCC 
CL761  CTGGATCCGCTGCCCCTCAACGCAGAAAG 
CL196  TACCGGGTTGGATTCAAGACGATA 
CL1047  AAGAGTCGAACAGCGAGAAGAGCTGAGGGTATTCGC







pIT-upp construction. In the early stages of development of the CSM method, it 
was first thought that the transposon reaction could be performed, followed by ligation of 
the linker and would result in only mutations in the gene of interest. However, in the first 
scan of GST, it was found that the intein was still functional if inserted into the N-
terminus of the VMA intein near the fusion. This led to the step of purifying the library 
by separating the members of the library that have the transposon inserted into the target 
gene from those where the transposon inserted else ware in the plasmid. To eliminate the 
purification step the N-terminus of the intein was truncated by using an individual clone 
containing a linker in the upp sequence and by inverse PCR removing 4, 8, 12, and 16 
amino acids. It was found that all were functional when plated on carbenicillin. It was 
unclear if it was due to where the linker was inserted into the gene or if the truncated 
intein where 16 amino acids was removed was actually functional. To verify if the intein 
can in fact be truncated at the fusion between the N terminus and the target gene, 
experiments would need to be done where an insoluble protein is inserted. If the splicing 
mechanism is not occurring then the E. coli would be sensitive in the presence of 
carbenicillin.  
When constructing the target plasmid for UPRT, only 4 amino acids were 
truncated. This was done by amplifying the pIT portion from pIT-GST using CL1008 and 
CL834, the 2899 bp product was purified. The gene encoding UPRT was amplified from 
pKQupp with CL761 and CL196 this resulted in a 1410 bp product which was then 
purified. Both pIT and upp were digested with BamHI and EcoRI, the upp digestion of 
the upp amplified product resulted in two bands, EcoRI was a restriction site that was in 




GH371 a upp knock out strain obtained from Jason Chin (MRC). In the presence of 1 μg 
mL-1 5-fluorouracil it was found that UPRT, although fused to the VMA intein was still 
functional. This confirmed that following the scan, subcloning of the mutant genes would 
not be necessary. 
SapI-GCG-intein-β-lactamase linker construction. The C-terminus and β-
lactamase were amplified from pIntSALect using CL1047 and CL1048 and Phusion 
polymerase. The 1391 bp product was purified and ligated into the EcoRV site of pLac-
upp. This plasmid was created by removing the N-terminus of the intein from pIT-upp 
and is used a general plasmid to clone blunt ended fragments. Selection of plasmids 
containing the insert are screened by transforming into GH371 and growing in the 
presences of 5-flurouracil. After successful ligation of the linker, the MlyI site in the β-
lactamase gene was removed using CL283 and CL284. The new linker is then removed 
from the plasmid by MlyI digestion, the 1391 bp band for the linker is purified by 
electroelution, followed by ethanol precipitation. This linker is now blunt and 
phosphorylated and can be ligated into a library. 
Deleting a triplet nucleotide. To delete a triplet nucleotide with the MlyI 
transposon, reaction conditions are identical to that that was previously described in 
Chapter 4. The only difference is that pIT-upp was used as the target plasmid. Removal 
of the transposon was performed with FD-MlyI, for 5 min. 
Inserting the SapI-GCG-intein-β-lactamase linker. The ligation of the linker 
with the library of linearized vector was performed as described in Chapter 4. Rather then 
removing the linker with MlyI, SapI is used to leave behind the GCG codon scar. The 




for 2 h. The mutant library ligation was then transformed by mixing 5 μL of the ligation 
reaction with 200 μL of chemically competent GH371 (upp deletion strain), recovered in 
1 mL SOC for 1 h and plated on LB agar supplemented with 50 μg mL-1 kanamycin and 
grown at 37 oC, which resulted in ~1000 individual colonies. From the library, 96 
individual colonies were picked into LB medium supplemented with 50 μg mL-1 
kanamycin in a 96 well block. The block was incubated with shaking at 37 oC until 
grown to saturation. 
Sequencing and selection of alanine mutants. The 96 well block was then 
replica plated on LB agar and M9 agar containing 0, 0,5, 1, 2, 4, and 8 μg mL-1 5-
fluorouracil. Colony PCR was done to show the plasmids were correct by amplifying the 
gene encoding UPRT with CL311 and CL196, the product of the PCR should be 
~2000bp and show that none of the plasmids have the linker still inserted. Plasmid DNA 
was then isolated by miniprepping the remainder of the liquid culture. All 96 individual 
plasmids were then sequenced at Yale Sequencing. Replica plates of the 96 well block 
were grown at both 30 oC and 37 oC, although in each condition the growth was identical. 
Any clones that are able to survive on 5-flurouracil would have a mutation that 






Chapter 6: Conclusions, Optimization and Future 
Applications 
6.1 Summary of Codon Scanning Mutagenesis 
 
Figure 6.1: Process of using CSM to create a random codon mutations. 
CSM requires four steps. 1) Transposon mutagenesis to insert unique restriction sites that allow for the 
double strand break. 2) Removal of the transposon and three nucleotides. 3) Ligation of a reading frame 
selectable maker carrying the mutation codon (TAG). 4) Removal of the linker to replace a native codon 
with the codon of choice, in this case a TAG. 
 
To date the developed CSM method is the only method that allows for generating 
defined, random, in-frame codon mutations. Two selection systems have been developed 
to obtain the in-frame mutations. It was found that the most efficient way of selecting for 
the correct reading frame is incorporating an intein into the selection limiting any protein 




selectable marker. The use of an intein allows for the selectable protein to be identical 
regardless of where the linker has inserted. The first selection method was based off of a 
non- biased reading frame selection plasmid that separates a head and tail region by the 
VMA intein. The second selection method was a thymidylate synthase selection and uses 
a self cleavage intein. This second system does not have a leader sequence that is 
required for protein function and this allows for possible out-of-frame mutations to occur, 
although very minimal, due to possible ribosome binding sites within the target gene. 
Each selection system has its advantages and disadvantages. The β-lactamase 
system would ensure that all mutations are in-frame by eliminating the synthesis of 
functional protein from an internal ribosome binding site. The disadvantage to this 
method is that some target proteins may not be functional when fused to the N terminus 
of the intein and therefore would require sub-cloning of the scanned mutant gene. Within 
the pIT plasmid two NdeI sites were incorporated on either end of the intein to allow for 
easy removal, although this adds an additional step to the method an intramolecular 
ligation is far more efficient then an intermolecular ligation. The advantage of the 
thymidylate synthetase selection is that scanning and assaying the mutant proteins can be 
done in all one plasmid but this library could be contaminated by out-of-frame mutations.  
During the development of CSM, a transposon was developed that allows for 
random in-frame codon deletions. This deletion transposon can be used to quickly and 
efficiently make protein truncations. While this has been developed using the β-lactamase 
system and requires the pIT plasmid, a transposon that uses the thymidylate selection can 




6.1.1 Bias observed 
In all the sequencing that has been performed on the mutants obtained from using 
the MuA transposase to introduce mutations it was found that mainly codons that have a 
high GC content were mutated. It was initially thought that it was due to the reading 
frame selection. However, after analyzing sequencing data that was obtained in the Cropp 
lab by Jia Liu, where three nucleotides were randomly deleted without a reading frame 
selection, it was found that the three nucleotides deleted were mainly GC rich. Shown in 
Table 6.1 is the codon that was targeted and the N2N3N4 from the duplication of 5 
nucleotides during the transposition reaction. Results are from 118 individual clones.  
Table 6.1: Frequency of mutations observed from CSM and random deletions. 
 
Literature precedence for a bias in the insertion of the MuA transposon. 
After sequencing both GCG-UPRT library and deletions from Jia Liu a trend toward GC 
rich codons was observed. Since the site of mutation is determined by the site of 




Although the transposon kits are marketed as being completely random, the removal of 
N2N3N4 from the initial five base pair duplication were analyzed from three recent reports 
of using the transposon,29, 64, 66 results shown in Table 6.2. The frequency of mutation 
observed is out of 238 clones. Naturally, the number of unique insertion sites was 
increased with the number of clones sequenced. However a bias towards codons with a 
high GC content was still observed. This bias can easily be seen when comparing the 
each row. The second row, where each codon begins with C, has a higher frequency of 
being targeted by the transposon. Both the second and fourth column, where C and G are 
the second base is also common sites for transposon insertion. 
Table 6.2: Frequency of N2N3N4 at the five base pair duplication site. 
 
6.1.2 Deep sequencing to confirm observed bias 
Based on the sequencing that was obtained in both scans using CSM as well as 
those which were performed by Jia Liu which uses the MuA transposase but for a 




observed in mutations that were found in the literature, shown in Tables 6.1 and 6.2. It 
would be interesting to determine if the AT rich codons are also being mutated but in a 
low frequency. A deep sequencing experiment82 could be performed on either of the 
libraries to validate that there is indeed a bias. Results of the deep sequencing experiment 
should show that all codons are mutated and the frequency at which the mutation occurs. 
As stated earlier the bias that we are observing may be that we have not sequenced 
enough clones. 
6.2 Optimization of Codon Scanning Mutagenesis 
Incorporating a defined set of multiple adjacent mutations. One limitation of 
this method is that only one mutation can be made at a time. The method could be 
adapted to scan a pre-chosen peptide linker, allowing for more then one codon to be 
mutated but would require that the codons are adjacent to one another. The methodology 
of deleting greater then 1 codon at a time is currently being developed by Jia Liu. Using 
the intein-β-lactamase selection system, he generated an asymmetrical transposon that is 
capable of selecting for the correct reading frame. The difference in the sequence on 
either end of the transposon allows for EIPCR to be performed to specifically place the 
restriction site for BsgI. The placement of the BsgI restriction site determines the number 
of nucleotides that can be removed. A linker segment with a defined number and 
sequence can then be inserted into the deletion plasmid, similar to a method termed 
transposon-directed base-exchanged mutagenesis (TDEM),83 which uses the same 





Figure 6.2: Asymmetrical transposon to delete in-frame codons. 
A) The difference in the four bases outside of the recognition site are highlighted in red. B) After successful 
transposition and selection the library is pooled and subjected to amplification. This step is necessary 
because mutations in the recognition sequence would result in little to no transposition events. The 
oligonucleotides introduce the BsgI recognition sequence (purple) and when digested there is a net loss of 
three nucleotides. 
 
A non-linker mediated codon scanning. The ability to use an asymmetric 
transposon that can select for the correct reading frame can also be adapted to replace a 
single codon. This modified method would eliminate the need to ligate in a segment of 




Liu is showing to be promising and would greatly enhance the speed at which CSM can 
be accomplished. Using a non-linker mediated codon scanning method may only require 
two library transformations and allow for libraries of mutations to be created within one 
week. The proposed method uses an asymmetrical transposon, one end has the MlyI 
restriction site and the other side the nucleotide sequence from Jia’s asymmetrical 
transposon, see Figure 6.3 A. A transposon reaction would first be performed, 
transformed and transposon insertions selected for on selectable plates. Since the DNA 
between the recognition sequences does not effect the transposition reaction, either of the 
two reading frame selectable systems could be used. Additionally, within the transposon 
sequence would contain the mutational codon and the restriction sites for MlyI and BsgI. 
After selection, all colonies from the library can be pooled and plasmid DNA isolated. 
Part of the transposon can be removed by MlyI digestion, followed by ligation. This first 
step would result in deleting N2N3N4N5 from the original gene sequence. Next a PCR 
reaction can be done on the ligation product, where one oligonucleotide would be an 
exact complement and the other would introduce an additional BsgI site. The PCR 
product can then be digested with BsgI to remove N1N2N3N4, blunted and ligated to leave 
the mutational codon in place of N2N3N4. While Figure 6.4 shows the MlyI digestion 
before the PCR amplification step, it is possible to amplify the library first, followed by 
the BsgI digestion and MlyI digestion. It is also shown in Figure 6.4 the mutational codon 
to be TAG, however just as in the mutagenesis method that was developed in this 
dissertation any codon of the users choice can be inserted. With this method it is also 





Figure 6.3: CSM without the need for linker ligation 
A) Proposed ends of an asymmetrical transposon where one end would have the recognition sequence for 
MlyI. B) After the transposon reaction and selection the library can be pooled. The codon to be mutated is 
in the transposon itself, with an MlyI and BsgI site on either side. Digestion with MlyI removes nucleotides 
up to N1, ligation would replace N2N3N4 with TAG. The library can be amplified to insert a BsgI site, 





Change the specificity of the MuA transposase. Engineering the MuA 
transposase to target A T rich regions of DNA would be a difficult task, since the 
transposition reaction is done in vitro. All mutant transposases would need to be purified 
separately and reactions done in individual wells with the donor DNA and A T rich target 
DNA. The five base pair gap would have to be repaired in vitro by adding a polymerase 
and dNTP’s after stopping the transposition reaction. After which, the DNA can be 
amplified by either PCR or rolling circle amplification (RCA).84 RCA, may produce 
greater amounts of DNA and the need for specific oligonucleotides is not necessary. If 
using RCA, an additional digest would be performed using an enzyme that has one 
restriction site in the target DNA. Either the linear RCA products or the PCR products 
would be analyzed by gel electrophoresis and in any lane with a band or larger band 
present would represent a successful transposition event.  
Recently, it has been reported that the target site preference of the transposase can 
be altered by adjusting both the buffer conditions and using a truncated transposase.85 
The authors had hypothesized that by increasing the amount of glycerol or DMSO would 
alter the target site preference and activity. This was based on previous reports stating 
that additives affect enzyme activity86 and can alter DNA binding.87 The buffer 
composition that was found to result in the most efficient transposition reaction as well as 
have a decreased target site preference is as follows; 25 mM Tris-Cl (pH 8.0), 5 mM 
MgCl2, 0.05% (v/v) Triton X-100, 110 mM NaCl and 10% (v/v) glycerol. The supplied 
buffers with the transposase do not contain glycerol or DMSO, Epicentre 1X HyperMuA 
reaction buffer: 150 mM KOAc, 50 mM Tris-OAc (pH 7.5), 10 mM MgOAc, and 4 mM 




with the difference being the composition of the buffer used in the transposition reaction. 
Both libraries can then be sequenced by amplicon sequencing to determine if mutations 
are more evenly dispersed over the target gene sequence. 
6.3 Proposed Future Applications of CSM 
The developed CSM method is extremely versatile. The desired amino acid 
incorporated into the library is user defined. Additionally, the codon that is chosen to 
create the library can be optimized depending on the organism in which the assay would 
be carried out. Linkers for all 20 amino acids can easily be produced and only requires 
that the linker sequence is amplified using an oligonucleotide carrying the codon of 
choice.  
Since, the CSM method allows for the any codon to be randomly distributed 
throughout any gene. This method should prove to be particularly useful in gaining 
insight in structure by scanning cysteines and protecting those that are solvent exposed, 
outlined in Figure 6.4. The CSM method coupled with the technique of labeling cysteines 
both intra and extra cellular (section 1.1), would be beneficial to understanding 
membrane bound protein structure. The data obtained from thiol protection assays could 
then be used to determine where to incorporate an unnatural amino acid, such as p-
benzoylphenylalanine site-specifically. The mutated protein can then be irradiated with 
360 nm light to promote cross-linking, followed by tryptic digests and analyzed by 
MALDI. This is also an example that could utilize the unique properties of the [D11]-





Figure 6.4: Cysteine scan to identify topology of a membrane bound protein. 
Using CSM, TGC mutations would be incorporated. The pool of mutations would be expressed with a C-
terminal His-tag in one flask. The sample would then be split and one protected with iodoacetamine. Both 
samples would then be treated with NTCB, purified and analyzed by SDS-PAGE. The non-iodoacetamine 
treated sample would give rise to multiple bands showing where as the iodoacetamine treated sample would 
have regions lacking a band, showing that those residues are solvent exposed. 
Naturally, if scanning a membrane bound protein, it would be feasible to simply 
scan the amber codon, TAG and incorporate pBpa in all places. However, as can be seen 
in with scanning pBpa though GST, there was not incorporation at every position, and 
this was only on a library of 10 mutants. By first scanning cysteine, non-functional/non-
folded members can be eliminated and only a small fraction of the original pool will be 




Protein-protein or protein-ligand interactions can also be addressed. This can be 
done by scanning natural amino acids and using a prokaryote two-hybrid system88 to look 
for disruption of interactions between proteins. Or the [D11]-pBpa51 can be scanned, 
followed by cross-linking and analysis using MALDI to determine interactions. As stated 
in the previous section, introducing cysteine residues followed by thiol protection assays 
would also aid in determining these interactions. 
Additionally this can allow for the creation of a novel protein with new activity. A 
transcriptional regulator protein can be evolved to be a light sensitive repressor by 
scanning the unnatural amino acid phenyalanine-4’-azobenzene (AzoPhe). The 
conformation of the double bond can be controlled by light by switching from cis to trans 
at 420 nm light and back to cis at 334 nm light, shown in Figure 6.5.  
Besides for scanning only one codon throughout a gene, multiple mutations can 
easily be created by repeating the CSM process. The ability to scan multiple mutations 
would be more feasible using the β-lactamase/ThyA linker, since selections can be done 
in the same plasmid. Doing multiple rounds of scanning, would introduce specific codon 
mutations. Further diversity can be introduced by recombining the mutant genes using 





Figure 6.5: Creating a light sensitive genetic switch. 
When AzoPhe isomerizes, both the conformation and dipole are changed, this would affect binding of the 
repressor to DNA. A system where the repressor (blue) controls the expression of a reporter (LacZ) can be 
constructed to assay the light sensitive genetic switch. The library of TAG-repressor mutants can be 
expressed under light in the presence of AzoPhe, when assayed in the presence of X-gal, any that are white, 
have wild-type repressor function. The white colonies can be expressed in the dark, isomerizing the 
AzoPhe and resulting in blue colonies, showing that there was a change in the binding site. This process 
can be repeated, each time amplifying the optimal mutation for a light sensitive genetic switch. 
 
6.4 Significance of Codon Scanning Mutagenesis 
This is the first example of combining two methodologies typically used in 
creating random protein diversity for inserting a specific codon mutation at a random 
place. The fusion of transposon mediated mutagenesis with the ability to select for the 




that the target DNA does not contain any of the restriction sites necessary to process the 
mutants, but with the ability to synthesize a gene any silent mutation can be incorporated. 
While CSM can mutate any position within a protein coding sequence having a high-
throughput selection for desired phenotypes of the target protein is desirable. The 
described method is also not useful in the case where one would want to only create a 
several site-specific mutants. This method should prove to be the most useful in cases 
where there is little or no structural data known. As well as, cases where the goal is to 
create new or enhanced protein function. 
 The aim of this dissertation was to develop a universal random mutagenesis 
method that incorporates a user specified mutation, allow for any mutation to be created, 
regardless of the nucleotide sequence and specifically introduce the mutation in the 
correct reading frame. This universal method, termed Codon Scanning Mutagenesis 
utilizes the unique properties of the MuA transposase to insert the type IIs restriction site 
MlyI at multiple non-specified locations within the DNA sequence. Removal of the 
transposon by digesting with MlyI removed a codon from the protein coding sequence. A 
linker segment that produces a seletable phenotype when inserted in the correct reading 
frame as well as carries the codon of choice is then inserted. Subsequent removal of the 
linker will leave the desired mutation without any net addition or deletion of nucleotides.  
In summary, Codon Scanning Mutagenesis, is the only method to date that allows 
the user to choose the codon that is to be randomly distributed throughout a protein 
coding sequence. Further, this is the only protein diversification method that can 
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